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The eye is embryologically, physiologically and anatomically linked to the brain. 
Emerging evidence suggests that neurodegenerative diseases, such as Alzheimer’s 
disease (AD), manifest in the retina. Retinal imaging is a quick, non-invasive method 
to view the retina and its microvasculature. Features such as blood vessel calibre, 
tortuosity and complexity of the vascular structure (measured through fractal 
analysis) are thought to reflect microvascular health and have been found to 
associate with clinical signs of hypertension, diabetes, cardiovascular disease and 
cognitive decline. Small deposits of acellular debris called drusen in the peripheral 
retina have also been linked with AD where histological studies show they can contain 
amyloid beta, a hallmark of AD. Age-related macular degeneration (AMD) is a 
neurodegenerative disorder of the retina and a leading cause of irreversible vision 
loss in the ageing population. Increasing number and size of drusen is a characteristic 
of AMD disease progression. Ultra-widefield (UWF) retinal imaging with a scanning 
laser ophthalmoscope captures up to 80% of the retina in a single acquisition allowing 
a larger area of the retina to be assessed for signs of neurodegeneration than is 
possible with a conventional fundus camera, particularly the periphery. 
Quantification of changes to the microvasculature and drusen load could be used to 
derive early biomarkers of diseases that have vascular and neurodegenerative 




Manually grading drusen in UWF images is a difficult, subjective and a time-
consuming process because the area imaged is large (around 700mm2) and drusen 
appear as small spots (< 125µm). An automatic approach to detecting drusen would 
overcome these challenges and facilitate investigations into drusen as a biomarker of 
neurodegeneration. In this thesis, an automatic system inspired by the recent 
successes of deep learning in medical image analysis was developed. As drusen are 
abundant in the retinas of people with AMD, a neural network was trained to classify 
patches in such a dataset of UWF images. This was compared to the manual gradings 
of two human observers. There was only a moderate agreement between observers 
(Kappa = 0.53, Average Dice Similarity Coefficient (DSC) = 0.38), reflecting the 
challenging and difficult nature of manually grading drusen in UWF images. 
Performances achieved for the automatic system (assessed using the area under 
curve (AUC) performance statistic) were 0.55-0.59, 0.62- 0.65 and 0.65-0.66 in the 
central, perimacular and peripheral regions of the retina, respectively. Highest 
performance was observed in a subset 8 images where observer agreement was at 
its highest (DSC > 0.8 and < 0.9), achieving AUC 0.55-0.59, 0.78-0.82 and 0.82-0.85 in 
the central, perimacular and peripheral zones, respectively.   
 
Measurements of the retinal vasculature appearing in UWF images of cognitively 
healthy (CH) individuals and patients diagnosed with mild cognitive impairment (MCI) 
and AD were obtained using a previously established pipeline. Following data 
cleaning, vascular measures were compared using multivariate generalised 
estimation equations (GEE), which accounts for the correlation between eyes of 
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individuals with correction for confounders (e.g. age). The vascular measures were 
repeated for a subset of images and analysed using GEE to assess the repeatability of 
the results. When comparing AD with CH, the analysis showed a statistically 
significant difference between measurements of arterioles in the inferonasal 
quadrant, but fractal analysis produced inconsistent results due to differences in the 
area sampled in which the fractal dimension was calculated. 
 
When looking at drusen load, there was a higher abundance of drusen in the 
inferonasal region of the peripheral retina in the CH and AD compared to the MCI 
group. Using GEE analysis, there was evidence of a significant difference in drusen 
count when comparing MCI to CH (p = 0.02) and MCI to AD (p = 0.03), but no evidence 
of a difference when comparing AD to CH. However, given the low sensitivity of the 
system (partly the result of only moderate agreement between human observers), 
there will be a large proportion of drusen that are not detected giving an under 
estimation of the true amount of drusen present in an image. Overcoming this 
limitation will involve training the system using larger datasets and annotations from 
additional observers to create a more consistent reference standard. Further 
validation could then be performed in the future to determine if these promising pilot 









During a routine optometrist appointment to check our eye health, we commonly 
have a picture taken of the back of our eye, called the retina. The retina can be 
imaged quickly and easily using a machine called a scanning laser ophthalmoscope. 
As the retina is connected to the brain, it has been discovered that changes that occur 
in the brain in relation to small blood vessels and nerves can be seen in the retina, 
which is more accessible to image. Alzheimer’s disease is the most common form of 
dementia and is a progressive disease, which means it gets worse over time. It causes 
deterioration of brain function such as memory loss (e.g. forgetting names of family 
members), problems with speech (e.g. mixing up words), disorientation (e.g. getting 
lost) and hallucinations (e.g. seeing and hearing things that are not there). The early 
sign of Alzheimer’s, called mild cognitive impairment, has symptoms of memory 
problems (e.g. forgetting to go to appointments) that is worse than you might expect 
with normal ageing. It is estimated that 850,000 people are living with dementia in 
the UK and this is predicted to increase to 2 million people by 2050. This places a 
heavy burden on healthcare providers as well as the families of patients. My research 
has looked at how the retina changes with Alzheimer’s to investigate what some of 
these changes are and whether they occur in an earlier stage of the disease. If we 
know how the retina changes in Alzheimer’s, in the future, an early warning could 




In an image of the retina, we can see the small blood vessels that carry blood in and 
out of the tissue. Sometimes there are small lesions, called drusen, that accumulate 
in the retina with age. These are more common in Alzheimer’s and other sight 
threatening conditions, such as age-related macular degeneration. Properties of 
blood vessels that are thought to reflect a person’s health can be measured using 
computerised techniques such as how their widths taper or how they spread out to 
deliver blood and nutrients to the retina. Drusen are difficult to count by hand 
because they are small and there are sometimes lots of them. This means that if we 
were to assess the retina for drusen changes in Alzheimer’s, a computerised 
technique is needed. Deep learning is a type of computerised detection or 
categorisation and is similar to how humans learn new things through examples. By 
teaching a deep learning system what drusen looks like and what normal retina looks 
like we can ask it to detect and count them. In my thesis, I developed such a system 
and compared its ability to identify drusen against two human observers performing 
the same task manually. There were limitations to my system. It failed to detect 
drusen that were very small which would result in an underestimation of drusen 
counts in my analysis, but it did provide for the first time a tool to automatically 
detect drusen in scanning laser ophthalmoscope images.  
 
Measurements of the retinal vessels from individuals that were cognitively healthy 
as well as those diagnosed with mild cognitive impairment and Alzheimer’s disease 
were compared. The analysis pointed to subtle differences in the retinal vessels in 
Alzheimer’s. Furthermore, drusen presence in mild cognitive impairment and 
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Alzheimer’s disease was different. My research contributed to the growing evidence 
that points to retinal changes in Alzheimer’s disease. Further work is now needed 
with larger studies and more images from individuals that have been captured at 
various time points in their lives to discover when retinal changes occur in the course 
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Chapter 1 Introduction 
 
1.1 Background and motivation 
 
Over 100 years ago Alois Alzheimer presented a lecture on a patient with “a peculiar 
disorder of the cerebral cortex” [1]. She had suffered from dementia and her brain 
was discovered to have protein plaques, neurofibrillary tangles and atherosclerotic 
changes that have now become defining features of Alzheimer’s disease (AD) [2]. The 
study of the molecular composition and mechanism of protein plaques and 
neurofibrillary tangles have since been identified as protein aggregate amyloid β (Aβ) 
and microtubule-associated protein tau [3][4][5]. These are now considered the 
hallmarks of AD. Atherosclerotic changes have also been defined as risk factors for 
AD, the most common form of dementia [6]. 
The aforementioned processes are not exclusive to dementia and there are parallels 
to other neurodegenerative diseases. Age-related macular degeneration (AMD) is a 
late-onset neurodegenerative disorder of the retina where progression to later 
stages results in irreversible vision loss. AMD and AD share many clinical and 
pathological features such as Aβ deposition in drusen and risk factors such as age and 
smoking. As the retina is anatomically, physiologically and embryologically linked to 
the brain there has been an increasing interest in utilising the retina to investigate 
diseases of the brain and central nervous system (CNS) [7]. The retina is in fact the 
only area of the body where microvasculature can be imaged non-invasively and has 
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been utilised to derive biomarkers of systemic conditions such as diabetes, cardio 
vasculature disease and renal diseases [7][8]. 
Imaging the retina is simple, non-invasive and inexpensive compared to magnetic 
resonance imaging (MRI) and positron emission tomography (PET), often used to help 
diagnose and research AD. With the advent of ultra-widefield (UWF) imaging more 
of the retina can be captured in a single image, including views of the periphery. This 
has created the opportunity to conduct a more extensive assessment of the retina 
for potential biomarkers of neurodegeneration. 
Currently there are few treatments and no cure for AMD or AD. Early diagnosis would 
improve patient care and aide in the development of preventative therapies that 
could prevent or slow down devastating vision and memory loss in the elderly. In an 
ageing population, AMD and AD become increasingly prevalent, placing pressure on 
healthcare providers by depleting resources and increasing financial strain. The 
burden is also increased for families of the patients who are affected. Non-invasive 
retinal imaging could help alleviate such pressures by providing an early diagnostic 
strategy and progression monitoring that can be achieved readily and easily.  
 
1.2 Thesis aims 
 
My study contributes to the need to investigate, characterise and assess changes in 
the retina in neurodegeneration. Automatic segmentation and analysis of the retinal 
3 
 
vasculature has previously been developed in UWF, however, automatic drusen 
detection has yet to be established. In this thesis I: 
1) Investigate methods for automatically detecting and analysing drusen in UWF 
retinal images. 
2) Implement and validate a computerised drusen detection system in UWF 
utilising images from people with AMD. 
3) Apply existing retinal vasculature analysis methods to a new cohort featuring 
patients with AD and Mild Cognitive Impairment (MCI) as well as cognitively 
healthy subjects. 
4) Apply novel drusen analysis to the above cohort to quantify drusen and 
characterise any differences in drusen load and location between the groups. 
 
1.3 Thesis outline 
 
In Chapter 2, I will consider the anatomy of the retina and its link to the brain. I 
will describe how the brain and retina are affected by neurodegeneration. Next, 
I will describe UWF imaging, how drusen may be a potential biomarker of AD in 
the retina with particular attention to the similarities between AMD and AD and 
highlight the need for drusen detection. In Chapter 3, I review the literature in 
the field of computerised drusen detection in order to inspire the direction of 
development for my system that I present in Chapter 4. Analysis of the patient 
cohort is reported in Chapter 5, including cohort characteristics and the 
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methodology for measuring the retinal vasculature in UWF images. In Chapter 6, 
I apply my drusen detection system to the patient cohort and present an 
exploratory analysis of drusen load and location. In Chapter 7, I discuss the 
























Chapter 2 The retina as the window to the brain 
 
2.1 The retina and brain 
 
The human eye is a unique and complex structure. Thought to have evolved around 
550 million years ago, it is the fastest muscle in the human body with 2 million 
working parts that allows us to see 500 shades of grey and 2.7 million colours. The 
eye is broadly comprised of three distinguishable layers (Figure 2.1). The inner most 
layer is composed of a complex structure of neurons, called the retina and is 
responsible for our ability to see. The outer layers consist of the sclera and cornea. 
The sclera protects and maintains shape of the eye. The cornea refracts and focuses 
light to the lens and retina, also protecting the eye from infection. The middle layer 
comprises the iris that controls the amount of light entering the eye and the ciliary 
body that provides aqueous production. Also, part of the middle layer, the choroid is 






Figure 2.1 Anatomy of the retina [10]. Here we can see the three main layers 
including the retina.  
Light enters the eye through the cornea and is directed to the lens by the iris. The 
lens then focuses the light to the retina. The retina is composed of highly specialised 
cells called cones and rods that are responsible for allowing us to see colour (Figure 
2.2). The light excites these cells converting the light signal to a neural impulse. This 
signal is passed through bipolar cells to the retinal ganglion cells (RGC) and eventually 
to the retinal nerve fibre layer (RNFL). The RNFL increases in thickness towards the 
optic disc (OD) that is connected to the optic nerve. The electrical signal then travels 


















Figure 2.3 Diagram of the eye-brain connection. The lens in our eye is much smaller 
than most of the objects we see. Light always travels in a straight line, so that when 
light is focused through the lens the image is upside down. The optic nerve goes 
through the optic chiasma to the primary visual cortex, or occipital cortex, at the back 
of the brain. This crossing of nerves allows us to register the image as right side up 
rather than upside down. 
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During embryological development the retina is formed from an outpocketing of the 
primordium of the brain and spinal cord, called the optic vesicle. The optic vesicle 
then invaginates to form the optic cup, where its inner wall becomes the neural retina 
and the outer wall, the retinal pigment epithelium (RPE). The retina connects to the 
brain through the optic nerve to the visual cortex in the brain. The retina is therefore 
a direct extension of the CNS. 
 
2.1.1 The progression of Alzheimer’s disease 
 
Neurodegeneration refers to any pathological process that affects neurons that 
degenerate by losing structure or function and can occur anywhere in the body. AD 
is neurodegenerative disease of the brain and the leading cause of dementia [11].  In 
2014, it was estimated that there were 850,000 people in the UK were living with 
dementia. This is projected to rise to 2 million people by 2050 [12]. Converging 
evidence from genetic at-risk cohorts and healthy ageing subjects have indicated that 
the pathogenesis of AD begins decades before diagnosis of clinical dementia [13]. 
Progression of AD is often thought to have three main stages: (1) presymptomatic, 
(2) prodromal and (3) symptomatic [14][15]. 
 
Presymptomatic stages of AD involve abnormal accumulation of Aβ due to abnormal 
metabolism of a large transmembrane protein called the amyloid precursor protein 
(APP) [16]. The exact physiological function of APP is not known but it has been 
shown to aide in neuronal growth and repair and is highly expressed and metabolised 
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in the brain [17]. Figure 2.4 shows the APP protein spanning a cell membrane. The 
left-hand side (blue) of Figure 2.4 is the normal pathway of APP processing while the 
right is the abnormal. Normal APP metabolism starts by α-secretase enzyme cleaving 
APP into a soluble protein that does not generate Aβ peptide [18]. There are genetic 
mutations that have been associated with the alteration of the APP cleavage site such 
as a mutation in the apolipoprotein E (APOE4) gene that has been shown to inhibit 
α-secretase and increase preferential cleavage by β-secretase (Figure 2.4A) [19]. 
Variation of the APOE gene (i.e. homozygous or heterozygous) determines the risk of 
developing sporadic (late onset) AD that accounts for 90-95% of AD cases [20]. PSEN-
1 (chromosome 14) or PSEN-2 (chromosome 1) that encode presenlin 1 and presenlin 
2 and are subunits of γ-secretase have been shown to increase APP cleavage by γ-
secretase (Figure 2.4B) [21]. PSEN-1 and PSEN-2 mutations are linked to familial (early 
onset) AD that accounts for 5-10% of AD cases [22]. Both APOE and PSEN mutations 
change the cleavage site of APP producing different length Aβ peptides. The 
incorrectly cleaved APP form Aβ oligomers that aggregate extracellularly and form 
diffuse or dense Aβ plaques (so-called amyloid plaques) between neuronal cells 
which can disrupt synaptic signalling and impair brain function (amyloidosis) [23][24]. 
Amyloid plaques and synaptic dysfunction can be identified in cerebrospinal fluid 









Figure 2.4 APP is a transmembrane protein and when cleaved at the Aβ domain by 
α-secretase results in a soluble protein that has been shown to have neuroprotective 
properties [17]. A) Mutations in the APP (APOE4) have shown to inhibit α-secretase 
cleavage and preferential cleavage by β-secretase (Sporadic AD) )[19]. B) 
PRESEN1/PRESEN2 mutations (Familial AD) increase γ-secretase enzyme [21]. Both 
(A) and (B) lead to excess Aβ peptide that accumulates in the extracellular space to 
form insoluble Aβ oligomers which can aggregate. Overtime the oxidative stress and 
consequential biochemical changes leads to neuronal cell death and the hallmark of 
AD, amyloid plaques [24]. Figure created at biorender.com.  
12 
 
A neuronal cell contains a cytoskeleton comprised of microtubules stabilised by the 
protein tau [26]. It is thought that the accumulation of extracellular Aβ oligomers 
activates pathways responsible for phosphorylation of tau, which then loses its ability 
to stabilise microtubules and promotes self-aggregation within the cell, called 
neurofibrillary tangles (NFT) [27]. Neurons with non-functioning microtubules cannot 
signal optimally which leads to apoptosis and atrophy of the brain, narrowing gyri 
(the folds of the brain), widening sulci (spaces between the folds) and enlarging of 
ventricles (cavities filled with CSF) [28]. Figure 2.5 shows a comparison of a healthy 
brain and neurons (left) and a brain with AD and neurodegeneration (right). AD starts 
from the hippocampus, the region of the brain responsible for making new 
memories, and progresses centrifugally [29]. Tau can be identified in CSF, MRI and 
blood in presymptomatic and prodromal stages of AD [30].  Prodromal AD is typically 
observed as cerebral amyloidosis with or without evidence of neurodegeneration 
and subtle cognitive decline mainly with episodic memory disturbances [14]. 
Cognitive testing in the tail end of prodromal stage of AD, such as mini mental state 
exam (MMSE) [31] or Montreal cognitive assessment (MOCA) [32], are often 





Figure 2.5 Summary of brain biomarkers of neurodegeneration in AD. On the left is a 
healthy brain and a healthy neuronal cell. On the right is a brain with atrophy, cortical 
and hippocampal shrinkage. Left shows a healthy neuronal cell which is responsible 
for communication and integration in the nervous system. The axon is the output of 
the neuron which branch to connect to other neurons. The dendrites are the input of 
the neuron and are covered in synapses that connect to other neurons. The axon is 
covered in a myelin sheath with periodic gaps (node of Ranvier) that serves as a rapid 
conductor of nerve impulses. On the right is a degenerating neuronal cell in an AD 
brain. Amyloid plaques and tau proteins impair neuronal cell input and output that 
block the dendrites and synapses. It is thought that an inflammation response causes 





Prodromal to symptomatic AD diagnosis usually occurs when a relative notices a 
cognitive problem, typically a memory problem, in a family member leading to that 
person seeking primary care such as from their GP and subsequent referral to 
secondary care which is often a memory clinic [33]. Early symptomatic stages of AD 
manifest as loss in short term memory (e.g. a person may not remember what they 
had for breakfast) and progresses to loss of motor skills (e.g. eating) and language 
(e.g. word recall) [34]. Later stages of symptomatic AD manifest as loss of long term 
memory (e.g. name of spouse), increasing disorientation (e.g. getting lost) and 
eventually individuals becoming bedridden [34]. The final symptomatic stage of AD 
can be difficult to diagnose from other dementias where cognitive testing is often 
used in the clinic [35]. MCI in some cases can be considered as the transitional stage 
of age-associated cognitive decline to AD [36]. Individuals are considered to have MCI 
if there is evidence that their cognitive function has declined but can still function 
independently in their daily lives. Such evidence is usually reported by a family 
member (e.g. a person used to be good at remembering their shopping list in the past 
but presently requires assistance to remember what to buy) [37].  
 
Figure 2.6 shows the hypothetical model of the succession of AD biomarkers in the 
brain [25].  Pre-clinical AD is hypothesised to occur as a succession of asymptomatic 
Aβ accumulation which can be identified in CSF and PET [38]. Amyloid plaques 
accumulate throughout the parenchyma as diffuse fibrils or more dense plaques later 
leading to synaptic dysfunction observed in prodromal AD and is identified using fMRI 
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[28].  Tau-mediated neuronal death is closely followed by atrophy of the brain, 
imaged using MRI [39]. This leads to symptoms of MCI and eventually dementia that 
is identified using cognitive testing. The risk of developing each disease stage 
increases with age. The preclinical period of succession of biomarkers therefore 




Figure 2.6 A hypothetical model and of the succession of AD biomarkers proposed in 
[25]. The dashed line indicates carriers of APOE4 allele may have detectable tau 
deposition before Aβ deposition [40]. Figure from [25].  
 
This raises the key question as to whether retinal changes occur prior to some of the 
aforementioned disease processes and would therefore translate to potential early 
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biomarkers or whether they are secondary manifestations of disease that might 
translate to biomarkers of AD progression. Advances in treatment’s for AD is largely 
symptom driven such as anti-Aβ antibodies for treating mild to moderate AD [41][42] 
which showed no improvement of clinical outcomes but a  sub analysis of mild AD 
found a slowed cognitive deficit [43]. This highlights the importance of early 
treatment and how early diagnosis would identify patients in the initial AD stages 
that could benefit from such interventions. Assessment and characterisation of the 
retinal changes in AD and MCI compared to cognitively healthy (CH) individuals may 
therefore help to identify when neuro-retinal degeneration occurs and what some of 
the measurable signs might be. 
2.1.2 Neuro-retinal degeneration 
 
As the retina is anatomically, physiologically and embryologically linked to the CNS it 
has been suggested that neurodegenerative diseases, such as AD, Parkinson’s disease 
and Huntington disease [44][45], may have pathology in RGCs (where APP is also 
synthesised) and the optic nerve in the retina [46]. Changes in the retina have also 
been observed in stroke [47][48], Parkinson’s disease [49][50] and Multiple sclerosis 
[51]. At a molecular level, Aβ and tau have been found within the retina and optic 
nerve [52][53]. There have been increasing reports of Aβ deposition in the retina 
[54][55][56] and this has been shown to trigger the breakdown of the RPE [57] and 
vascular integrity of the retina [58]. Tau deposition reduces axonal transport in retinal 
neurons that causes a toxic affect to RGC’s [59], ultimately leading to RGC apoptosis 
and thinning of the RNFL [60][61][62][63] and optic nerve abnormalities [64]. 
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Furthermore, previous studies using animal models have reported a correlation 
between the deposition of senile plaques in the retina (composed of Aβ and Tau) and 
senile plaque load in the brain [65]. Retinal senile plaques in mouse models have also 
been detected prior to plaque deposition in the brain, suggesting Aβ deposition in 
the retina may be an early sign of AD [52]. In histological studies in humans, Aβ 
deposition have been found in extracellular deposits in the retina, called drusen [55].  
The development of the retinal microvasculature is a highly coordinated process that 
involves internal cell-cell signalling and external stimuli such as oxygen and nutrients 
to optimise blood flow in the retina [66][67]. Therefore, deviations from this 
optimum state can lead to damage within the retina. There have been reports of 
associations between vascular changes and the neurodegenerative process of AD 
[68] such as Aβ deposition in the retinal vasculature that has been shown to increase 
stress on the blood vessel walls leading to morphological and functional changes [69].  
 
Neurodegenerative disorders also have overlaps with diseases unique to the eye, 
such as axonal atrophy observed in glaucoma and Parkinson’s disease [70][71] and 
drusen in AMD and AD [55]. Given that there are shared features between 
neurodegenerative disorders and other ocular pathologies, precise characterisation 
of retinal changes in each condition would be required to distinguish early AD 
biomarkers from sight threatening conditions. The retina can be assessed through 
ophthalmic examination using retinal imaging, which is a quick, non-invasive 
procedure and causes hardly any discomfort to the patient. Retinal changes may be 
extremely subtle and so precise measurements are needed in order to investigate 
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associations with AD. In this thesis, drusen deposition (that may indicate Aβ 
deposition) and changes in the microvasculature are assessed using UWF retinal 
imaging in order to investigate retinal changes that might occur in AD.  
 
2.2 Ultra-widefield retinal imaging to study AD 
 
2.2.1 UWF retinal imaging 
 
Retinal imaging has evolved over the past 40 years as a technology. In parallel, our 
understanding of many diseases has increased. The oldest and most widely used 
retinal imaging modality is fundus photography, which has been used to view the 
macular, optic disc, retinal abnormalities occurring close to the surface of the retina 
(e.g. geographic atrophy (GA), haemorrhages), the retinal vasculature, RPE and 
lesions (such as drusen and diabetic retinopathy lesions). Fundus photography 
typically provides a 35-50° field of view (FOV) of the retina using white light to 
illuminate the scene and capture a colour image (with a typical resolution of about 
7μm). Optimum results are achieved through induced dilation of the pupil where 
more light can enter the eye to illuminate the retina. Multiple fundus images can be 
captured by various gaze positions and then stitched together to achieve a larger 
FOV. However, montaged images often have small misalignments that could lead to 
erroneous measurements plus a patient can become fatigued from multiple flashes 
from the camera system. Figure 2.7 shows fundus photographs and the optical 






Figure 2.7 Example fundus photographs that can be captured using a fundus camera. 
A) A fundus photograph has a 35-50° FOV. This photograph is macula centered with 
the OD to the left. B) Example of a fundus camera. This camera is a Canon CR-DGi and 
has a 45° FOV. C) Example of a montage of fundus photographs where 5 fundus 
photographs have been acquired at different gazes and stitched together. Montage 
image from [72].  
 
Scanning laser ophthalmoscopy (SLO) is a method where a laser scans across the 
fundus illuminating the retina point-by-point. Combining SLO technology with a 
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series of lenses and mirrors, a UWF image can be acquired. The retinal imaging 
modality used in this thesis is the Optos UWF-SLO and can capture 200° of the retina 
(approximately 80%). Figure 2.8 shows an Optos UWF-SLO instrument and an 
example UWF image. Optos SLO is recognised for delivering fast, high resolution 
imaging in terms of sharpness and contrast without the need for pupil dilation and is 
less susceptible than fundus cameras to any media opacities such as cataracts, 
amounting to real advantages when imaging an elderly population [73]. The UWF-
SLO camera uses red (633nm) and green (532nm) lasers to scan across the retina 
where the reflected light is collected by lenses and mirrors onto a photodiode and 
returned to its original red and green components creating a digital image 











Figure 2.8 Example of an Optos UWF image and an Optos UWF-SLO instrument. A) 
An Optos UWF image (called an optomap) that is used in this thesis. The image 
consists of a red channel that is obtained by the red laser (633nm) and a green 
channel that is obtained by the green laser (532nm). In this thesis the images 
acquired do not have a blue channel but the camera system contains a blue laser 
(488nm) that is used for fluorescein angiography procedures and an infrared laser 
(802nm) used for indocyanine green angiography procedures. B) An Optos UWF-SLO 
California model that has a 200° FOV. Earlier models include the P200Tx and Daytona.   
 
Given the large FOV of a UWF instrument, the curvature of the retina must also be 
taken into account when analysing the image to measure features. Compensating for 
distortions, due to the retinal curvature, is achieved through stereographic projection 
[74]. The image is mapped computationally to a standard model of a human eye using 
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the position of the OD and the fovea as reference points. This image is then flattened, 
much like projecting a map from a globe, to enable more accurate measurements of 
distance. This process also allows measurements on the image to be converted from 
pixels to millimetre equivalents [74]. Figure 2.9 shows an example of a 
stereographically projected UWF image and the anatomical landmarks. 
 
 
Figure 2.9 Projected UWF image of a healthy individual. The OD is the bright centre 
of the image and the fovea can be seen as a dark spot. Images are acquired centred 
on the fovea. In the image we can see lashes in the inferior nasal quadrant (Q3). 
Lashes also appear in superior temporal quadrant (Q1), as they create bright 
refection’s. In this thesis, I consider any area outside a typical fundus camera FOV 




UWF imaging allows the periphery of the retina to be investigated for changes 
occurring with disease. There are anatomical differences between the central and 
peripheral retina, such as more cone photoreceptors in the former and more rods in 
the latter[75]. Manifestations of disease in the retina may vary between central and 
peripheral zones. Imaging a large area of the retina could prove to be beneficial for 
increasing our understanding of disease mechanisms or deriving biomarkers of eye 
and brain conditions. Indeed, UWF has utility for monitoring peripheral post-
operative tears from cataract surgery that may result in retinal detachment [76]. 
UWF has also been used to derive additional retinal abnormalities in diabetic 
retinopathy. The outcome was that diabetic retinopathy severity was graded more 
severe in UWF images than in the corresponding fundus photograph and therefore 
the larger FOV provided more information about the extent of the disease and 
resulted in a more accurate diabetic retinopathy grading [77]. This suggests that 
there is additional information in the periphery that could have clinical utility that is 
not accessible with a conventional fundus camera. UWF imaging therefore provides 
an opportunity to assess a larger area for potential biomarkers of AD. 
 
2.2.2 Drusen as a potential biomarker of AD 
 
Drusen are small deposits of acellular polymorphous debris that gathers between 
Bruch’s membrane and the RPE, which is shown in Figure 2.10, and are considered 
the hallmark of AMD. AMD is a neurodegenerative disorder of the retina and is one 
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of the leading causes of vision loss in the elderly, costing the UK economy £155million 
in 2011 [78]. Reporting to have affected 6 million people worldwide in 2014 [79], 
AMD is projected to increase to 288 million globally by 2040 [79]. Early AMD is 
observed as presence of (asymptomatic) macular drusen, often found incidentally 
through ophthalmic examination, such as from routine optometric examination. 
Although presence of drusen alone is not diagnostic of AMD, as drusen occur in 
normal ageing, increasing number and size increases the risk of progression to 
symptomatic AMD [80]. Late AMD presents as pigmentary changes of the RPE prior 
to the development of GA (Dry AMD). As neurodegeneration of the RPE progresses, 
abnormal blood vessels grow (neovascularisation) that are fragile and can leak fluid 
and blood. This results in scarring of the macula and exudative abnormalities (Wet 
AMD) and ultimately leads to irreversible vision loss. However, the exact 
pathogenesis of drusen progression in AMD is incompletely understood and 









Figure 2.10 AMD pathogenesis in respect to the layers of the retina. Drusen 
accumulates between the RPE and Bruch’s membrane. Fluid leaks within the layers 
as a result of neovascularisation and can result in irreversible vision loss. Image from 
[84]. 
 
Drusen are broadly categorised into two main types, hard and soft, where AMD 
severity is usually graded according to the size, number, type of drusen and or the 
presence of GA and exudative abnormalities [85][86]. Drusen are also characterised 
on a variety of attributes, where in the context of retinal imaging they are subtyped 
based on their borders. Red and green wavelengths pass through the retinal layers at 
unique depths so that each channel within the returned image contains different 
information (Figure 2.11A). Red light wavelengths travel further to the choroid layers 
whereas shorter green light wavelengths, where drusen is situated, travels to 
photoreceptor and RPE layers. This makes drusen more clearly observed in the green 
channel (Figure 2.11B). Hard drusen are round discrete lesions (< 125µm) with 
defined borders and tend to be brighter in appearance (Figure 2.11C). The largest 
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component of hard drusen is cholesterol (40% of drusen composition) where at the 
core there is a high abundance of non-esterified cholesterol that gives drusen its 
round and bright appearance in a retinal image [87][88]. Soft drusen have less 
defined borders (>125µm) and are often confluent with the RPE or decrease in 
density from centre outwards with fuzzy edges (Figure 2.11D). Soft drusen are often 
larger than hard drusen (diameter greater than 1000µm) and are composed of loose 
granulated membranous debris that gives its diffuse and punctate appearance in a 



















Figure 2.11 Types of drusen. A) Schematic of light from the lasers in the UWF 
instrument reaching different layers to capture different information. The red light 
reaches lower depths of the retina such as the choroid, where the green light 
captures more shallow information at the RPE where drusen is situated. B) Drusen is 
most clearly observed in the green channel of a UWF image. This patch from a UWF 
image contains many hard drusen that are brighter than the surrounding RPE. C) Hard 
drusen are assessed on the basis of their distinct borders. Hard drusen are small 
discrete lesions that are often round and bright due to their high cholesterol content. 
D) Soft drusen have more diffuse edges with decreasing brightness from the centre 
outwards. Drusen are much harder to distinguish from the texture of the RPE because 





Figure 2.12 shows what drusen looks like in a UWF image. They are observed as bright 
yellow or white spots on the retina where hard and soft drusen can appear 
simultaneously and often cluster. Drusen can be found near blood vessels, the 
macular and the OD and in various other locations. Drusen can also be similar 
appearance to dust artefacts from the mirror of the imaging instrument. 
 
 
Figure 2.12 Drusen in a UWF image. Drusen are heterogeneous in composition and 
exists as many types. Soft drusen and hard drusen can appear simultaneously. Soft 
drusen often form clusters and can be described as a ‘starry-sky’ pattern. 
 
In this thesis, drusen is an interesting potential biomarker of AD because there have 
been reports of a higher abundance of hard drusen in the peripheral retina of AD in 
post mortem tissues [90] and observed in UWF images [91]. AMD and AD have similar 
risk factors (such as obesity, smoking, hypertension and ageing), share pathways of 
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inflammation and share a decreased capacity of ageing cells to remove damaged 
proteins that are also regulated by specific protein pathways [92][93]. There have 
also been reports that Aβ deposition is specific to drusen from eyes of patients with 
AMD compared to drusen in normal ageing eyes where increased Aβ assemblies may 
be associated with advanced AMD [94][55][56][95].  As there are many similarities in 
the pathogenesis of AMD and AD this suggests that Aβ-targeting therapies being 
tested for AMD could be applied to AD (and vice versa) [93]. However, it is important 
to note that the presence of drusen in AMD and AD in a retinal image does not 
immediately indicate Aβ deposition which could only be confirmed using post 
mortem biochemical analysis. 
 
There has been recent efforts using curcumin, that binds to Aβ fibrils, to image Aβ 
load in vivo [96]. This study used an automated method to quantify curcumin 
fluorescence spots in the retina (using an autofluorescent camera system) that was 
suggested to indicate Aβ deposition where they found more fluorescent spots in AD 
participants [96]. The limitations of this study were that the participants were 
required to drink shakes that contained high doses of curcumin where the fluorescent 
spots were automatically quantified using a method that was not validated against a 
reference standard (i.e. a human observer) which is needed to evaluate algorithm 
accuracy [97].  
 
Optical coherence tomography (OCT) is a non-invasive, high resolution retinal 
imaging technique which uses light waves to form cross-sectional images of the retina 
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(typically 30° (height) 21° (volume) FOV; up to 5µm axial resolution; 2mm A-scan 
depth; up to 6 x 6mm scan area). Measurements of the retinal architecture can be 
obtained and has been used extensively to study changes in mild cognitive 
impairment and AD. Two meta-analysis [98][99] have shown decreased retinal RNFL 
thickness is correlated with MMSE scores and cognitive decline. Thinning of the 
ganglion cell-inner plexiform layer and RGC complex has been observed in AD 
[100][101]. In an OCT image, soft drusen appear as white mound like elevations of 
deposit under the RPE whereas hard drusen have a prolate or blunted triangular 
shape (sometimes described as a ‘saw tooth’ pattern).  Recently, OCT has been used 
to shed light on the clinical entity of reticular pseudodrusen that accumulate above 
the RPE that was not previously observed in fundus photographs [102]. OCT is 
currently proving to be a valuable method for drusen grading and allows drusen types 
to be assessed within the layers of the retina [103]. OCT angiography (OCTA) is a non-
invasive high-resolution retinal imaging technique used to visualise the 
microvasculature (typically 3x3mm scan area) and has also been used to assess 
retinal changes in AD. A loss of retinal vessel density, that may indicate accumulation 
of Aβ,  in AD and MCI compared to controls has been reported [104][105]. 
 
To the best of my knowledge there has only been one study that has used UWF 
imaging to fully characterise, drusen load and location in AD where there was 
significantly more hard drusen in the peripheral retina in AD [91]. In this study, the 
UWF image was assessed for drusen by overlaying a grid onto the image (see Chapter 
4) and manually annotating each grid cell for drusen types. Although the use of UWF 
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imaging provided a larger area of the retina to be assessed than could be achieved 
by a fundus, OCT or OCT-A device, manual grading for drusen in the large FOV is a 
time-consuming process and would be challenging to apply this method of drusen 
grading to a larger dataset. 
 
2.2.3 The need for automatic drusen detection 
 
In the clinic, ophthalmologists use their expertise to identify types of drusen in a 
retinal image based on their appearance, with the aim to identify any pathology that 
may be sight-threatening or causing disturbances in vision. Hard drusen would not 
need to be treated as they are common in normal ageing but would require regular 
follow up to make sure they do not develop into soft drusen that may indicate early 
signs of AMD [106][107]. Such manual grading and or quantification of drusen is a 
time-consuming task where automatic computerised drusen detection to analyse 
retinal images would alleviate this challenge and aide the ophthalmologist in 
stratifying patients for regular follow up. In a research context, finding new 
associations between drusen and disease would require studies involving the 
quantification of drusen. However, manual quantification and grading of drusen is 
difficult and subjective due to their varying nature and similar texture to the ageing 
retina. In a UWF image there is a large FOV where manually quantifying drusen would 
be especially difficult and time-consuming. An automatic approach could therefore 
provide a solution to these challenges and a method to investigate drusen and 
disease in large datasets as well as monitoring progression in longitudinal studies. In 
32 
 
this thesis, a computerised automatic drusen detection was developed to allow for 
the quantification of drusen to discover new associations between AD, MCI and CH 
individuals. It is envisaged that through quantifying drusen in AD and MCI and 
comparing to CH individuals, there may be unique characteristics between the groups 
that could indicate early biomarkers of AD in the retina. 
 
2.2.4 Analysing the retinal vasculature to study AD 
 
There have been numerous studies employing vessel width calibres, vessel tortuosity 
and global branching complexity (fractal dimension) to investigate retinal changes in 
the context of microvascular health and disease [7]. In a large metanalysis (10,229 
participants) vessel width calibres measured from fundus imaging and expressed in 
the form of common summative parameters central retinal vein equivalent (CRVE) 
and central retinal artery equivalent (CRAE) have clinical relevance for predicting 
hypertension [108]. The ratio of CRAE and CRVE, AVR has also been shown to have 
associations with a decrease in AVR in diabetes mellitus [109] and stroke [110]. 
Higher fractal dimensions (FD) have been observed in proliferative diabetic 
retinopathy [111] whilst lower FD has been observed in AD [112][113] in fundus 
imaging and UWF [91]. Associations between increased retinal tortuosity’s and 
cardiovascular disease as well as with high-density lipoprotein cholesterol have 
previously been observed in fundus images [114]. To exploit the large FOV of the 
UWF image and investigate vessel width changes in the peripheral regions a novel 
parameter, vessel width gradient (WG), was extracted from the largest vessel path in 
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each quadrant. Venular WG (WGv) has previously been observed to decrease in AD 
[91].  
 
Such quantitative measures have been extracted from fundus images using semi-
automatic specialist software such as SIVA (Singapore ‘I’ vessel assessment) and 
VAMPIRE (Vessel assessment and measurement platform for images of the retina) 
[115][116]. In this thesis the retinal vasculature was analysed using an extension of 
VAMPIRE for semiautomatic analysis of the retinal vasculature in UWF images [117] 




Associations between retinal changes and neurodegeneration is a longitudinal 
question to be addressed. In AD for example, it is unclear as to whether retinal 
changes occur prior to clinical symptoms such as marked cognitive decline and could 
therefore be used to identify preclinical AD, or whether these changes appear later 
in the disease process. In order to accurately and reliably quantify and monitor 
changes in the retina (both in the posterior pole and periphery), novel methods need 
to be developed. Automatic drusen detection could be used to provide quantitative 
measures to investigate associations with drusen and disease as well as monitoring 
progression in longitudinal studies. While the retinal vasculature can be measured in 
UWF images using existing software, we have no system for automatic drusen 
detection in UWF images. In part, this is because drusen are ambiguous, difficult and 
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time-consuming to label in UWF images due to their varying nature. The imaging 
characteristics of drusen (i.e. bright, yellow and round) are similar in fundus 
photographs and UWF images of AMD and AD. Therefore, a system that detects 
drusen would have the potential to detect drusen in any disease where the 
quantification of drusen load and location may provide insight into associations 
between drusen and the disease of interest (i.e. AD). This compels an investigation 
into previously developed automatic methods for detecting in fundus images in order 



















Chapter 3 Investigating automatic detection of 
drusen 
 
3.1 Introduction  
 
The focus of this chapter is the investigation into developing automated drusen 
analysis in UWF-SLO. Automatic drusen detection is an under-developed area for this 
imaging modality but is comparable to drusen detection in conventional fundus 
photography. This compels an investigation into which strategies have been utilised 
in previous fundus imaging work and to identify recent state-of-the-art techniques 
that are of relevance to my thesis, with the aim of assessing techniques that are 
applicable to UWF-SLO. The investigation was conducted as a systematic review 
[118]. The objective was to identify and critique the methods adopted in various 
algorithms and report their performance against a reference standard. Methods 
identified from the literature were then tested on UWF images and are also described 
in this chapter. This information was used to guide the development of drusen 







3.2 The literature search 
 
3.2.1 Search strategy 
 
To filter articles featuring automatic drusen detection a computerised search of 
EMBASE, PubMed, Web of Knowledge, ScienceDirect, ACM Digital Library and IEEE 
Xplore was conducted using search terms “drusen” and in combination with 
“detection” or “classification” or “identification” or “segmentation” or 
“quantification” or “measurement” or “algorithm”. Titles and abstracts were filtered 
on whether they contain “age-related macular degeneration” or “AMD” or 
“Alzheimer’s disease” or “AD” to identify articles featuring only AMD and AD. 
 
3.2.2 Inclusion and exclusion criteria 
 
Articles were included only if they were an original study, written in English and 
evaluated performance of the algorithm against at least one human grader. Articles 
were excluded if they were a review, non-human research, non-English language, did 
not use fundus photography (e.g. OCT) and if the performance of the algorithm was 




The process of algorithm validation consists of showing that the algorithm performs 
correctly through comparison of output to a reference standard [97]. The reference 
standard is defined here as the manual grading of an image by a human. Performance 
is usually reported as a statistic such as sensitivity, specificity, accuracy and ROC (see 
Chapter 4 for definitions of these terms). Another aspect is the size of the dataset 
used to validate the algorithm. If a small number of images had been used to test the 
algorithm this might not be representative of a larger target population. Fundus 
photographs vary between individuals in the extent of disease manifestation or 
image quality. This means that an algorithm tried out on a small dataset may perform 
well in the testing phase but fail to generalise to the larger population where more 
complex data is likely. Articles that validated their proposed system on less than 50 




Figure 3.1 shows the results of the literature search as a flow diagram. The initial 
search returned 2,236 articles in 2017. A further 1,318 articles were excluded after 
filtering for AMD and AD, such as articles featuring glaucoma (42 articles) and diabetic 
retinopathy (45 articles). 834 from the remaining 918 articles were excluded as they 
did not use fundus photography (18 articles), were not an imaging study (770 articles) 
or were reviews (34 articles). 73 articles did not meet the inclusion criteria where 9 
articles did not report a performance to a reference standard, 14 articles validated 
on fewer than 50 fundus photographs, 3 articles featured software optimisation and 
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2 articles reported hardware. Following bibliography search of the remaining articles, 
1 additional article was identified that met the inclusion criteria. 5 other articles were 
included following a hand search for the year 2018 and 2 articles were included for 
the current year (2019). This totalled 16 articles where 11 articles used machine 
learning techniques and are discussed in this chapter. 5 articles reported deep 
learning techniques and are discussed in section 4.2.3. 
 
During the search, an earlier review of drusen detection in fundus imaging was also 
identified [119]. At the time this article was published the techniques considered 
conventional image processing operations as opposed to machine learning 
techniques. None of the articles discussed met my exclusion and inclusion criteria 
and were not included in the systematic review [118] but were considered in this 
thesis for the investigation into drusen detection in UWF. Notably, these articles did 
not report performance to a reference standard. In order for such systems to be 
deployed in studies involving drusen quantification, knowledge of their accuracy 
would be required to determine if the automatic measurements can be interpreted 
with a degree of confidence. To the best of my knowledge, there are no publicly 
available datasets that contain manual annotations of individual drusen to validate a 




3.3 Conventional image processing 
 
Conventional image processing is a term used in this thesis to refer to methods of 
extracting information from images using digital processing that requires no learning 
stage. Such methods involve performing operations on an image to either enhance 
the image or to extract information from it. Drusen is a characteristic sign of early 
AMD and grading protocols use size, number and type [120][121][85] to determine 
AMD severity and monitor progression where earlier efforts to quantify drusen 
involved conventional image processing techniques to segment drusen [119]. 
Application of such techniques often need a pre-processing step to address noise that 
might be present in a fundus image and non-uniform illumination.  In a fundus 
photograph the shape of the retina, vignetting at the edge of the pupil and media 
opacity contributes to non-uniform illumination across the FOV when illuminating 
light from the imaging system enters the eye at particular angles. Fundus 
photographs also contain a black border that needs to be removed as this does not 
contain any relevant information. Objects that appear bright in a fundus photograph, 
such as the OD, need to be considered during image processing. These challenges are 
also present in UWF imaging. 
 
3.3.1 Drusen segmentation in fundus photographs 
 
Histogram based approaches have previously been applied to fundus photographs to 
segment drusen [122][123]. Pixel values in an image range from 0 (black) to 255 
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(white) in each of the red, green and blue (RGB) colour channels. An image histogram 
is the frequency of occurrence of intensity across all the pixels. This allows the 
number of pixels that have a particular intensity value to be visually inspected and 
where the shape of the histogram provides information pertaining to the overall 
quality of the image, characteristics of objects and the potential for enhancement. 
Rapantzikos et al [123] proposed a histogram based algorithm for segmenting local 
regions of drusen in fundus photographs called histogram adaptive thresholding 
(HALT). The authors observed that histograms of windows containing drusen had a 
positively skewed distribution with a peak of bright pixels. To obtain a segmentation 
from a histogram, Otsu’s thresholding approach, a well-established thresholding 
method that finds the threshold that maximises the variance between peaks in a 
histogram [124],  was used to segment drusen regions from the background. The 
result was that there was no need to correct for non-uniform illumination or remove 
border pixels. The algorithm worked well on clearly defined drusen but failed on 
drusen that were vague, small or located inside bright regions, within noise and near 
vessels. Checco et al [122] used a variety of noise removal (random variation of 
brightness or colour in an image) and histogram normalisation that equalises pixel 
intensities across the intensity range to correct for non-uniform illumination and to 
enhance drusen in a manually defined local region in a fundus photograph. A 




Figure 3.2A shows the pixel intensity profiles of selected regions in a UWF image 
extracted over a set distance of 110µm, which is approximately the same size as the 
smallest window in [123]. The regions and corresponding signal of intensity profiles 
contain abrupt changes related to objects in the image. The profile plot shows three 
large peaks of bright pixel intensities that were sampled from hard (Figure 3.2D) and 
soft drusen (Figure 3.2E) as well as objects that are thought to be dust inside the 
imaging system (Figure 3.2G). The lower intensities of these profiles are similar in 
behaviour to the profiles pertaining to RPE of early AMD (Figure 3.1B) and RPE of an 
older eye (Figure 3.2C) and a blood vessel (Figure 3.2G). This figure shows that 
although drusen in a UWF image have a characteristic pixel intensity distribution, 
certain features within the drusen profile can be similar to those found in other 
objects such as the intensity of the RPE and can occur simultaneously with intensity 
of other objects such as blood vessels. This highlights how using a histogram method 






Figure 3.2 A) Intensity profiles of different regions in a UWF image sampled over a 
distance of 110µm. B) sample of early AMD RPE, (C) sample of older healthy RPE, (D) 
sample of hard drusen, (E) sample of soft drusen, (F) sample of ambiguous object that 
could be either drusen or dust, and (G) sample across a blood vessel. 
Segmentation of drusen in fundus images using texture has previously been proposed 
[125]. Texture is a nebulous concept where its interpretation sometimes depends on 
human perception but mathematical definitions for quantifying it are also available. 
Drusen are different in texture and colour than the normal appearing retinal surface. 
For a computer to understand this and use texture content to segment drusen, we 
need to describe it in a numerical form. There are many methods to extract texture 
information from an image such as using histogram properties, morphological 
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operations and filter based techniques, and it is a rich and long standing field of 
computer vision [126][127]. In the previous figure, the intensity profiles reflected, in 
part, the texture of different objects in the UWF image. These signals can therefore 
be utilised to describe texture.  
A standard method uses a Fourier transform that convolves a signal into its sine and 
cosine wave equivalents and into the frequency domain [128]. In an image, each pixel 
in the Fourier transform will correspond to the intensity of the wave and the position 
of the pixel corresponds to the frequency and orientation of the wave. The aim of the 
Fourier transform in image processing is to select certain waves that have a specific 
frequency and orientation that represents the object of interest. A wavelet is a rapid 
decaying oscillation that has 0 mean and exists for a finite duration in different sizes 
and shapes. A wavelet can be scaled to a larger factor that stretches the wavelet and 
corresponds to a lower frequency or can be scaled by a smaller factor that shrinks 
the wavelet and corresponds to a higher frequency. A low frequency wavelet when 
passed over a Fourier transform signal will capture slowly varying changes in a signal 
and a high frequency wavelet will capture abrupt changes. The wavelet can be shifted 
along the signal so that it is in line with the feature or object of interest. This type of 
processing in the frequency domain is called filtering and is used to smooth, sharpen 
and enhance images. Filters can be applied to the Fourier transform in order to 
manipulate a specific frequency, such as by amplifying and attenuating the signal, so 





Figure 3.3A shows pixel intensity values sampled across a UWF image where the 
arrows indicate the peaks and troughs corresponding to whether this signal is from a 
blood vessel, drusen or the retinal surface (Figure 3.3B). A Fourier transform was 
applied to the signal transforming it into the frequency domain where high frequency 
spikes correspond to high intensity values (Figure 3.3C). This operation was applied 
to a whole image and Figure 3.3D illustrates its effect on a small image patch that 
contains drusen. A Fourier transform of the image is represented in the frequency 
domain which consists of a signal with magnitude (the intensity of the wave) and the 
phase (the position of the wave). The image is reconstructed using the phase and 
magnitude to re-transform the image back into the spatial domain. This results in an 
enhanced image where drusen appear better defined as do the vessels but there is 
still some high frequency noise. A Gaussian filter is a filter that has a Gaussian shape 
that can be used to remove high frequency components whilst preserving high 
frequency edges (i.e. it is a low pass filter) [129]. In Figure 3.3D, a Gaussian filter is 
applied to the Fourier transform that results in a reduction of noise and an 
enhancement of the edges of drusen and blood vessels. Parvathi et al [125] proposed 
using a Gabor filter (a Gaussian wavelet modulated by a sinusoidal plane) to filter a 
manually defined region of interest (ROI) in a fundus photograph for high frequency 
components that correspond to edges of drusen to obtain a segmentation. This 
method required OD and blood vessel suppression by masking the OD and replacing 
the dark pixels from blood vessels in the green channel with the local mean of the 
pixels in the image. Since a Gabor filter can have multiple shapes and scales, this 
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method required parameter tuning (i.e. selecting the optimum shapes, size of the 
filter) and could only be applied in local regions of a fundus photograph.  
 
 
Figure 3.3 Applying a Fourier Transform to a UWF image to enhance drusen.  A) 
Shows a blue profile line indicating where pixel intensity values were sampled. B)  
Displays the distance along the sample line plotted against pixel intensity. C) The 
Fourier transform of the signal into the frequency domain. Hypothetical Gaussian 
filter is overlaid where it can be passed along the signal to filter high frequency noise.  
In this example the Gaussian filter is placed over a region of high frequency that 
would be removed to reduce noise. D) Each processing step applied to an image 
patch containing drusen. 
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Morphological operations have previously been applied to fundus photographs to 
segment drusen [130]. Morphological processing involves defining a structuring 
element such as a binary circle or a square and placing it at every location over the 
input image and comparing it to the surrounding pixels. This can switch on the pixels 
that are black (i.e. replace with 1) within the neighbourhood defined by the 
structuring element (dilation) or remove pixels at the boundary (erosion). The result 
from a dilation is that objects in the binary image become larger in shape and in an 
erosion, they become smaller with some detail removed. Sbeh et al [130] proposed 
a structuring element derived from the region maxima of the pixel intensity profile 
of drusen. This method applied the structuring element to a manually defined ROI 
that was smoothed using a median filter. The challenge with this method was that 
the structuring element could only be applied to local regions of drusen at the fovea 
and gives coarse results when extending to the image as a whole. Figure 3.4 shows a 
structuring element applied to the processed image patch from the previous figure. 
Firstly, the background is defined as the Gaussian filtered image and is subtracted 
from the green channel resulting in an enhancement of drusen pixels (Figure 3.4A). 
As drusen are circular in appearance, a circle or disk structuring element was defined 
with a diameter of 10 pixels (Figure 3.4B). The structuring element is applied over the 
image as a dilation to extend bright objects into the shape of a circle (Figure 3.4C) 
and the border pixels are removed (Figure 3.4D). The result is a grey image that can 
be thresholded by selecting all grey values above 0 and the boundary of the resulting 
mask is traced onto the original grey image (Figure 3.4.E). Bright drusen are 
48 
 
segmented in the centre of the image and the use of a morphological operation 
creates a smooth outline of drusen. 
 
 
Figure 3.4 Application of morphological processing using a disk structuring element 
to the patch of drusen in a UWF image from Figure 3.3D after gaussian filtering. The 
purpose is to obtain segmentation of drusen in the image. A) Gaussian filtered image 
that is subtracted from the green channel and results in an enhancement of drusen 
pixels. B) Binary disk structuring element with a diameter of 10 pixels. C) The 
structuring element is applied over the greyscale image as a dilation to extend bright 
objects into the shape of a circle. D) The border pixels are removed using connected 
components. E) The image is thresholded by selecting all pixels that are above the 




3.3.2 Drusen segmentation in UWF-SLO 
 
The methods described in Section 3.2.1 for fundus camera imaging were applied to 
UWF imaging in order to assess whether they might be suitable for segmenting 
drusen in these types of images. Conventional image processing methods posed four 
main challenges. The first was the presence of non-uniform illumination, which would 
make drusen appearing in the centre of the image brighter but darker in the 
periphery, and so a segmentation method would need to be robust to such 
variations. Second, the presence of other bright appearing objects such as the OD 
might need to be suppressed to reduce the number of false positives. Thirdly, 
traditional methods seem to perform well on image patches but often failed when 
applied to the full image in one go. Finally, segmentation methods work well on hard 
drusen that have clearly defined edges as opposed to soft drusen that are blurrier in 
appearance. What these methods had in common is the use of the green channel on 
which segmentation of drusen was performed as they are most visible against the 
retinal tissue in this colour channel (see chapter 2). With these challenges in mind, a 
combination of histogram, texture-based and morphological based methods were 
tested on a fundus photograph and then applied to a UWF image.  
 
Figure 3.5 shows a fundus photograph (green channel only; 2336x3504 pixels) 
containing drusen and the corresponding image histograms as the input image is put 
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through the initial processing steps. Figure 3.5A shows the input image and Figure 
3.5B shows the same photograph but the OD region suppressed, which was achieved 
by manually outlining the OD boundary and setting pixels within this region to black. 
In the corresponding image histogram there is a non-uniform, left-skewed 
distribution of pixel intensities where removal of the OD decreases a small peak in 
bright pixels (denoted by the magenta arrows). Non-uniform illumination correction 
was applied to both images using a Top-hat filter that is a form of morphological 
filtering using a structuring element (in this method a disk of radius 20 pixels) to 
perform morphological opening that is subtracted from the original image [131]. The 
result is an image where the larger bright objects are removed whilst keeping the 
smaller ones (i.e. possible drusen) (Figure 3.5 C and D). This results in a narrower and 





Figure 3.5 Correcting non-uniform illumination in a fundus photograph using a Top-hat filter. A) The green channel of the fundus 
photograph as a grey scale image with an area where there is a mixture of soft and hard drusen marked (white box). It can be seen that 
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the centre of the image is lighter than peripheral areas of the image.  B)   The region corresponding to the OD has been suppressed 
manually which has reduced a small peak of bright pixels (magenta arrow). C) Top-hat filtering of the green channel leads to an 
enhancement of drusen as well as an image histogram that has a normal distribution between a narrower range of pixel intensities. D)   




To extract texture content from the image, a Fourier transform with a Gaussian filter 
was applied and subtracted from the filtered green channel, as in Section 3.3.1.   
Figure 3.6A shows the output with (left column) and without OD suppression (right 
column).  The result is that smaller brighter pixels that are different in texture to the 
rest of the image have been enhanced, but there is still some noise within the image 
from small bright regions. To extract the larger objects that could be drusen and 
reduce the noise, a second disk structuring element (10 pixels) is applied to the image 
(see Figure 3.6B) that reduces noise while the larger brighter objects that may be 
drusen are enhanced. However, this operation has also enhanced the bright regions 
around the OD even with suppression.  To remove this, the image was binarized by 
selecting all pixels above the value of 0 (black) and the largest object, identified using 
connected components whereby an object in an image is identified as being part of 
the same object by scanning neighbouring pixel values, was removed. Figure 3.6 C 
shows the removal of this region (magenta) in the images without and with OD 








Figure 3.6 Texture based segmentation with morphological filtering of a fundus 
photograph without OD suppression (left) and with OD suppression (right). A) image 
segmented by texture. B) Morphological filtering using a disk structuring element of 
10 pixels in diameter. (C) Removal of the object with the largest area (green) from 
the smaller objects (magenta). (D) Final binarized image. 
Figure 3.7 shows the final binary segmentations overlaid onto the original fundus 
photograph where it can be seen that there is a high number of false positives in 
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segmentation when the OD was not suppressed. Also shown is a close up of the green 
channel with outlines of candidate drusen overlaid. By visual inspection, the black 
arrows indicate drusen that has been correctly segmented while the red arrows 
indicate false positives that occur around blood vessels. The green arrows indicate 














Figure 3.7 Result of texture-based segmentation overlaid onto a fundus photograph 
without OD suppression (A) and with (B). C) A close up showing a section of the green 
channel overlaid with outlines of the segmentation output. Black arrows indicate 
drusen that have been correctly segmented while red arrows indicate false positives 
near blood vessels and green arrows indicate false negatives where soft drusen with 
less defined edges were unsuccessfully detected 
Figure 3.8A illustrates the result of the method applied to a UWF image (with the OD 
suppressed). The image contains clusters of hard and soft drusen as well as eye lashes 
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that have covered some of the FOV. The face plate is also apparent in the image and 
contained dust particulates over its surface, and there is a dark spot near the OD. This 
is a representative example of a challenging UWF image because it contains large 
amounts of drusen, non-uniform illumination and artefacts (some of which have a 
similar appearance to drusen, i.e. dust). Visually, the segmentation method has 
worked well to identify drusen clusters but has produced a false positive 
segmentation of the face plate. Given that previous work performed well on image 
patches, a cropped section of the image was segmented separately and is shown in 
Figure 3.8B where it can be seen that some hard drusen have been identified but also 
a region that containing both hard and soft drusen as well as normal retinal tissue 










Figure 3.8 Application of traditional image processing technique to segment drusen 
in a UWF. A) UWF image containing large clusters of hard and soft drusen. Eyelashes 
are present in the bottom of the image as well as a portion of the face plate that 
appears due to sub-optimal patient positioning at image acquisition. There is a dark 
artefact near the OD that could be vitreous material. B) Segmentation of a local 
region in the central area of the UWF image. Black arrows indicate drusen that have 
been correctly segmented while the green arrows indicate false negatives and the 
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yellow arrow indicates how the segmentation has been unduly influenced by 
artefact. 
As previous grading protocols have used drusen size, type and number to monitor 
drusen progression and severity [120][121][85], the segmentation result would not 
be able to return this type of information accurately. In addition, one of the major 
challenges with some of the previously discussed work discussed is that there was no 
reporting of segmentation performance against a reference standard. This is because 
manually segmenting drusen by hand is labour intensive and subjective. Although 
conventional image processing may produce promising results in a visual sense, 
without validation to a reference standard their performance cannot be assessed 
quantitatively.  
 
3.4 Machine learning 
 
The results from the aforementioned literature search showed a trend moving away 
from traditional image processing techniques (reviewed in [119]) towards novel 
machine learning approaches where the overall aim is to classify an image into a 
particular class. Machine learning is a subfield of artificial intelligence (AI) and is 
based on how humans learn from past experiences. For example, an individual can 
decide whether they like an item of clothing or not based on the colour and 
brightness or intensity. In Figure 3.9 this shown as a plot where the points indicate 
whether an individual likes an item of clothing (green dot) or not (red dot). From this 
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data we can deduce that this individual does not like dark red clothing but likes bright 
blue clothing as it is linearly separable. Based on this previous knowledge, when we 
are presented with a new item of clothing that is bright blue, we would be able to 
predict that this individual will like this item of clothing. However, if we have another 
item of clothing that has a medium intensity and is green in colour, it is unclear as to 
whether they will like or dislike the item. This is where machine learning can be used 
to model scenarios where the features that define the data are more complex than 
colour and intensity but can be used to predict the group that new data belongs to. 
In this example, one could decide that item 2 is closer to more ‘likes’ than ‘dislikes’ 
and therefore it is a predicted to be a ‘like’. Such an algorithm or technique is called 
k-nearest neighbours (KNN) and is an early form of machine learning. Just as an 
individual can learn what they “like” and “dislike” about an object and use this to 
decide what they might think about new object, so too can a machine learning 
algorithm use previously learned features from the data to predict a classification for 






Figure 3.9 Illustrating the concept of classification. The example shows two features 
that an individual might use to decide whether they like an item of clothing or not. 
The known information is plotted and could be separated using linear regression, 
where this individual seems to like bright blue clothing but dislikes dark red clothing. 
If we have a new item of clothing that is bright blue, it is plotted (magenta data point), 
and we can see that the individual will most probably like the item. When presented 
with a more difficult decision that is an item of medium intensity and green in colour 
(yellow data point), the data is no longer linearly separable and would require a 
different method to predict which group it belongs to. In this example we could use 
the neighbouring data points to decide the label for the new item of clothing. This is 




When the data is an image, features from the data need to be extracted. This is often 
referred to as handcrafted features and is manually designed by identifying 
distinguishing features in an image relating to the object of interest. An 
ophthalmologist can distinguish features of a disease such as GA or drusen, but an AI 
algorithm will need to extract features from pixels that pertain to an object such as 
drusen. In Section 3.3 a technique that exploited the brightness, colour and texture 
of drusen was used to segment drusen from the retinal background. This can be 
extended to more complex features derived from properties within the image to 
build a classification algorithm that separates the data into the desired classes. These 
features can either be learned from previous examples (supervised learning) or 
determined by the algorithm (unsupervised learning). Figure 3.10 [118] shows an 
example of a supervised learning pipeline. First, the image is pre-processed to 
enhance image features or to reduce noise. Next, features such as measures of 
entropy (properties from the pixel intensity levels in an image), energy (properties 
from histogram distribution), texture and geometric properties are extracted from 
the image. This is transformed into a numerical vector that typically undergoes a 
feature selection stage, whereby the best features that describe the data are 
selected. At the so-called training stage, a classification algorithm is applied to use 
patterns learned in the data to distinguish subgroups. In order to validate the 
algorithm, a testing set is then input into the trained classifier and used to classify 
new images into subgroups. The results from the literature search (see Section 3.2.3) 
will be discussed in terms of these machine learning steps and are subsequently 
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applied to a set of UWF images to classify them into classes - early AMD, older eye 
and younger eye. 
 
 
Figure 3.10 Example of a supervised machine learning pipeline from [118]. 1) The 
image is preprocessed either to reduce noise or enhance features of interest in the 
image. 2) Features such as pixel intensities, geometric properties and textures are 
extracted. 3) Features are converted into a numerical vector and undergoes a feature 
selection stage where the best features that distinguish classes are selected. 4) A 
classifier is trained that separates the data into the subgroups. 5) Training generates 
a mathematical function that separates the classes. 6) Testing images are input into 
the trained classifier to identify which group the image belongs to and this is validated 




3.4.1 Study designs and populations 
 
The 14 studies that met the inclusion and exclusion criteria used 4 publicly available 
datasets (ARIA [132], STARE [133], AREDS [134], RetinaGallery [135]), 3 used private 
datasets, 1 article sourced fundus images from a telemedicine platform and 1 article 
used images from an independent study [136]. Although each article used different 
methods some articles used the same datasets. Four articles aimed to classify fundus 
photographs as disease or no disease, 6 articles aimed to classify AMD into severities 
using the AREDS grading protocol [86] or an in-house grading protocol (Cologne 
Image Reading Centre and Laboratory (CIRCLE)). 2 articles aimed to classify Dry AMD 
vs. Normal images and 1 Wet AMD vs. Dry AMD or Normal. Table 3.2 summaries the 
dataset and cameras used for each of the 11 articles [118]. 
3.4.2 Preprocessing and feature extraction 
 
Similar to conventional image processing, properties from the image histogram (e.g. 
energy, entropy and intensity) have commonly been used for classifying regions that 
contain drusen or not. To improve contrast in an image Contrast Limited Adaptive 
Histogram Equalisation [137] has been used frequently [138][139][139][140][141]. 
This technique flattens the image histogram to make the image equal in colour 
intensity that results in an enhanced image in the sense that the image appears to 
have more definition between objects in the image (i.e. more contrast) Following 
removal of the black border, median filters have been used to smooth high frequency 
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noise [142][143]. Grivinsen et al [144] employed intensity and contrast features from 
manually defined boundaries of drusen that to train a classifier. Burlina et al [145] 
used conventional image processing techniques such as median filtering, 
morphological dilation and thresholding to obtain regions of no drusen (background) 
and drusen. Garcia-Floriano et al [146] exploited  mathematical morphology to 
segment regions of drusen and the macular that was subsequently used to extract a 
quantitative measure of pixel intensity shape called a Hu moment. The type of 
preprocessing applied depended on the particular features to be extracted. These 
studies all exploited drusen colour and intensity from an enhanced green channel to 
derive a mathematical definition of drusen that could be used to distinguish them 
from other objects present in the image (i.e. background, optic disc, macular). Hijazi 
et al [138] replaced blood vessels with null values in their proposed system where 
removal of black border was not required. Table 3.1 summarises the preprocessing 








3.4.3 Feature selection 
 
As it is possible to extract many features from an image, it is necessary to select the 
best descriptors of the object(s) of interest that achieve the best classification 
performance. The feature selection stage involves removing potentially noisy or 
irrelevant features and identifies salient features that can be used to best distinguish 
between classes. Six of the articles from the literature search employed a feature 
selection stage. Zheng et al [140] used a L2 loss function to reduce noisy pixel 
intensity features. The output is a list of top features that were best for distinguishing 
images of disease and no disease. Garcia-Floriano [146] used a software package 
[147] to identify highly correlated features to disease and no disease. Mookiah et al 
[139][148] used parametric (e.g. t-test) and non-parametric tests (e.g. Wilcoxon 
ranking) to determine the top features for distinguishing disease from no disease. 
They reported a texture feature from a Gabor filter as the best performing feature. 
Acharya et al [141] used an algorithm inspired by ant behaviour and crossover 
operators in genetics to identify top features for classifying dry AMD and wet AMD 







The classification stage is the process of using the best features that represent the 
data to identify a model that separates the data into the desired classes. A dataset of 
images is typically separated into a training set used to develop the model and a 
testing set used to validate the performance against a reference standard. The 
evaluation of an algorithm’s performance is commonly reported in terms of statistics 
such as receiver operating characteristic (ROC), accuracy, sensitivity and specificity 
(see section 4.3.4 for a definition of these terms).  
3.4.4.1 Disease/no disease 
 
Classification is the process of taking the input features and mapping to a discrete 
label such as disease or no disease. There are many classifiers available and the choice 
of which one to use depends on the nature of the data and its application. Table 3.2 
summarises previous work used for classifying disease or no disease in fundus 
photographs [118]. Hijazi et al [138] used a case-based reasoning (CBR) technique to 
classify images containing disease (AMD) or no disease from histogram-based 
features. CBR is an automated reasoning and decision-making process whereby new 
problems are solved using experience accumulated from solving previous problems. 
Hijazi et al [138] used a 2-step CBR system whereby histogram features from the 
green channel with the blood vessels removed was the first case and the second case 
consisted of the same image but with the removal of the OD. The model was built by 
72 
 
storing the training image features for classes of AMD and no AMD so that when an 
image was passed into the CBR system it would compute the similarity between the 
learned AMD and no AMD features. The output was whether the input image was 
similar to AMD or no AMD where the highest similarity would be the prediction for 
the image. They reported a 75% accuracy for correctly classifying AMD images. 
Burlina et al [145] proposed a constant false alarm rate (CFAR) algorithm that is used 
in radar systems to distinguish true signals from noise to determine the origin of the 
signal. The CFAR system used colour features to train a support vector machine (SVM) 
classifier. An SVM classifier is a form of regression whereby features are projected 
into a higher dimensional space so that classes are linearly separable. They reported 
a positive predictive value of 97% and a negative predictive value of 92% at classifying 
images that contain disease (i.e. pathology that may indicate an unhealthy retina) or 
no disease. Zheng et al [140] proposed an algorithm that represented training images 
as a hierarchical tree where the child and parent nodes were derived from colour and 
intensity features of the image. They reported best classification using an SVM 
classifier that achieved a 99.4% sensitivity. An SVM classifier was also used by Garcia-
Floriano et al [146] to classify images as disease or no disease from pixel intensity 








3.4.4.2 AMD severity  
 
The AREDS grading protocol used drusen size, count and type to define AMD severity 
into four classes [134]. Table 3.3 summarises classification of AMD severity in fundus 
photographs [118]. Phan et al [143] proposed a machine learning system to classify a 
dataset of fundus photographs into AREDS classes consisting of class 1 {1} for healthy 
images, class 2 {2} mild AMD (containing small drusen <63µm), class 3 {3} moderate 
AMD (containing drusen between 63µm and 125µm) and class 4 {4} advanced AMD 
(containing many drusen with geographic atrophy). They employed a “bag of words” 
algorithm that used the most salient features in the image and counts the frequencies 
and bins them into a histogram. The so-called visual vocabulary consisted of colour 
features where they used an SVM to classify the images into the AREDS classes. They 
reported a best performance for classifying {1} vs {2} vs {3} vs {4} at an accuracy of 
62.7%. Similarly, Kankanaballi et al [142] exploited colour features to generate a 
visual vocabulary from images of high quality and low quality (i.e. images containing 
artefacts or poor lighting) and different numbers of images in the training set of each 
AMD class.  They reported a highest accuracy of 98.9% for classifying images into 
AMD classes from a classifier that was trained from images of high quality with a 
balanced number of images per class. This accuracy decreased to 96.1% as low-
quality images were included. Grivensen et al [144] proposed a system to quantify 
drusen area, size and location to classify images as low risk or high risk AMD. This 
involved segmenting drusen using Gaussian filters of the green channel and K-nearest 
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neighbours to determine whether a pixel belonged to drusen or not. From the 
segmentation they derived drusen area and diameter and compared this to the 
manual measurements from two human observers. From the segmentation, colour 
and texture features were extracted to train a random forest classifier that classifies 
a high or low risk images. They evaluated the algorithm according to its agreeability 
between the observers using intraclass correlation coefficients (ICC) and reported an 








Table 3.3 Summary of applied machine learning techniques to classify fundus photographs into AMD severity categories [118]. ACC, 
accuracy; SEN, sensitivity; SPEC, specificity; PPV, positive predictive value; NPV, negative predictive value; AREDS, Age Related Eye 
Disease Study; EIPC, equal number of images; MIPC, maximum number of images per class MS, manually selected images.
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3.4.4.3 Wet/dry/no disease 
 
Table 3.4 summarises previous work used for classifying wet or dry AMD from normal 
in fundus photographs [118]. Mookiah et al [139][148] used multiple features derived 
from the CLACHE enhanced images pixel intensities to train an SVM classifier to 
classify between fundus photographs of dry AMD and no AMD. They reported best 
performance of 95%. Similarly,  a SVM was used by Acharya et al [141] to detect wet 
AMD from dry AMD using gradient features. There was an imbalance in the number 
of wet AMD image (21 dry to 1 wet) and used oversampling of the minority class to 
balance the data. They reported an 85.1% accuracy for detecting wet AMD from dry 
and normal images. Both of these proposed systems did not require any retinal 












3.4.5 Machine learning for UWF-SLO classification 
 
3.4.5.1 Materials and methods 
 
22 early AMD (17 right, 5 left), 62 older eyes (30 right, 32 left) and 40 younger eyes 
(19 right, 21 left) UWF images were used in this thesis to train a classifier to 
distinguish the images into their categories. Images were captured using an Optos 
UWF-SLO (Daytona, Optos plc, Dunfermline, UK) and shared by Optos. This 
represents a challenging dataset to classify for three reasons. The first is that the 
appearance or texture of the retina looks similar for older eyes and early AMD. In the 
ageing retina there is a decrease in the abundance of RGC’s and photoreceptors 
[149]. In a UWF image and fundus photograph this is perceived as varying levels of 
colour and texture. As AMD risk increases with age this texture would also be present 
therefore it would be challenging to distinguish between early AMD and a retina that 
is ageing healthily. Second, in a younger eye there is an abundance of RGC’s in the 
posterior retina that are bright in appearance and could resemble drusen. Finally, the 
variation in image quality is often taxing as an older individual may not be able to 
open their eye sufficiently wide enough at image acquisition leading to eyelash and 
eyelid artefacts in the image. Additionally, older participants may not be able to sit in 
an optimal position at the device which causes bright reflection artefacts that occur 
in the centre of the image. In this dataset there is a variation of image qualities in 





Figure 3.11 Representative examples of UWF images in each group. The top row of images is considered to be good quality as there is a 
large FOV with minimal eyelash and eyelid obstruction. The bottom row of images is considered to be poor quality because of the eyelash 
and eyelid obstruction.  A)  Right eye of individual with early AMD, clusters of hard and soft drusen are present near the macular. B) Left 
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eye of an older individual without AMD that contains temporal tessellations (thin choroid). C)  Right eye of a younger individual that 
does not contain drusen but bright healthy RGC ‘s surrounding the macula.  D) Right eye of an individual with early AMD and of poor 
quality. There are numerous clusters of hard and soft drusen from the central retina towards the periphery. E) Left eye of an older eye 
of poor quality, much of the image is obscured by artefact. F) Right eye of a young individual that is poor quality due to the obstruction 
of the eyelashes and lid that covers a large portion of the inferior retina. 
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The dataset in Phan et al [143] consisted of four severities of AMD (see section 3.4.4.2 
for definitions of the AREDS class) - where class 1 and class 2 is a similar problem to 
older eye vs early AMD eyes, and trained the classifier using high quality and low 
quality images. This gave good results using a bag of words feature extraction method 
with a Gaussian kernel SVM classifier.   
In section 3.3.2 an image histogram was defined using the frequency of pixel 
intensities in the image, likewise a histogram can be defined using the features 
contained within an image, called a visual vocabulary. First, the training image was 
divided into a grid (with overlap) and Speeded Up Robust Features (SURF) was 
extracted from the image within each grid cell [150]. Next, the extracted features 
were clustered using K-means (a method used to group data points into a specified 
number of clusters) whereby the centre of each cluster is a visual word. The 
frequency of occurrence of each visual word was obtained for each training image 
and defined each image histogram (i.e. the visual vocabulary). A KNN (see section 3.4) 
and SVM classifier was trained using the visual vocabulary as features. An SVM 
classifier is a well-established technique that projects features into a higher 
dimensional space so that classes are separable (i.e. finds a decision boundary that 
maximises the space between data points closest to the boundary). The function that 
transforms the features into the new space and constructs the SVM is called a kernel 
where there exist many types, such as linear, radial basis function kernel (or gaussian 
kernel), polynomial and sigmoid, where choice of kernel depends on the nature of 
the data.  
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Given that Phan et al [143] had good results with a similar dataset, a bag of features 
algorithm was applied to extract features from the UWF images. Next, a SVM and 
KNN classifier was trained and evaluated on UWF images of 8 early AMD (4 right, 4 
left), 15 older eyes (7 right, 8 left) and 10 younger eyes (5 right, 5 left). The value of 
the hyperparameters grid size, overlap, number of K-means clusters and kernel 
method can be determined by iteratively tuning the hyperparameters and evaluating 
the classifiers performance. In this thesis, a high performance was obtained in the 
first iteration using a grid size 32 x 32-pixel, 8 x 8-pixel overlap, 500 clusters for K-
means and a Gaussian kernel. 
3.4.5.2 Results 
 
The evaluation metrics of accuracy, sensitivity and specificity (see section 4.3.4 for a 
definition of these terms) were used to assess the performance of the classifiers. 
Table 3.5 displays the results for the testing set. SVM achieved the highest sensitivity 
(88.9 %) and specificity (100%) compared to the KNN classifier. The KNN classifier had 
1 false positive that predicted an older eye to be early AMD and 1 false negative that 
predicted 1 image as an older eye when the true label was early AMD. Figure 3.11 
shows the false positive and false negative UWF images for the KNN classifier. The 
false negative could have arisen due to the low abundance of drusen present in the 
image. The false positive could have occurred due to the bright eyelashes in the 
image that could be interpreted as bright drusen. Although the image was not 






The machine learning methods presented in this chapter showed a tendency to use 
the green channel of a fundus photograph to extract features for training a classifier 
to discriminate images into the applicable categories. The most consistent features 
were texture-based  and colour-based where multiple classifiers were often tested 
to determine the best model [143] [42] [42] [29] [140] . In some articles, retinal 
landmark suppression such as removal of the blood vessels or OD was required to 
improve performance [138] [143] [146]. In the articles that aimed to classify AMD 
severity the most difficult classes to distinguish were mild to moderate AMD. In the 
clinic, distinguishing between these two classes requires drusen size or load, 
measurements that could not be obtained without segmentation of drusen. There 
was a common trend of image-level classification. Only one article quantified 
individual drusen [144]. Image-level classification of fundus photographs could be 
used for large scale screening to identify individuals who may be at risk of developing 
severe AMD. Whereas segmentation of individual drusen could be used to monitor 
subtle longitudinal changes. However, without a sufficiently large dataset containing 
hand drawn annotations of drusen boundaries, it would be difficult to train and 
validate a system with an acceptable performance. 
In this thesis, KNN and SVM classifiers achieved good performance for classifying 
images into early AMD, older eye and younger eye categories. False positives 
occurred due to the objects appearing in images which looked similar to drusen as 
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well as the resemblance between older eyes and eyes with early AMD. A false 
negative with the KNN classifier identified an image that contained drusen. Machine 
learning techniques are trained on examples that are assumed to be representative 
of the population. However, new images may not be similar to the training images 
and may result in misclassification. Machine learning algorithms require hand crafted 
features which may not generalise to the whole population (so-called overfitting).  
The results of the literature search identified a recent trend towards deep learning 
techniques that have been developed to address the challenges that conventional 




Conventional image processing can be used to segment drusen but there is a 
shortage of a reference standard to validate the algorithm against. Without a 
quantitative measure of an algorithms accuracy, interpretation of any subsequent 
measures may not be reliable. Machine learning is a valuable method for image-level 
classification and yields good results on the UWF image testing set. However, these 
methods often fail to generalise to datasets that are different and or more complex. 
A trend towards deep learning methods after 2015 was observed in my evaluation of 
the literature, which is reflected in the current state-of-the-art for many areas of 
medical image processing. Deep learning and its application to drusen detection is 













In this chapter, the development and testing of automatic drusen detection in UWF 
retinal images is described. First, I introduce the concepts of deep learning and 
transfer learning before a drusen detector is trained using transfer learning. This 
detector is then tested on its ability to classify image patches as containing drusen or 
no drusen and the results compared to the annotations of two human observers. The 
aim of this chapter is to develop a novel method to detect drusen in UWF images.  
 
4.2 Deep learning and transfer learning 
 
Deep learning has become state-of-the-art for computer aided detection in medical 
imaging [151][152]. There is a demand for quick, reliable and accurate interpretations 
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of medical data from a medical expert. In a healthcare setting, these interpretations 
can be limited by the subjective nature of the process, image complexity, high 
interpatient variability and human error. Deep learning is an advancement that has 
potential to provide solutions to these limitations by aiding the clinician with 
particular tasks with high accuracy, reliability and repeatability [153]. Unlike machine 
learning (as discussed in chapter 3), deep learning does not require any feature 
engineering but rather extracts features directly from data. First, I will discuss the 
building blocks of a convolutional neural network (CNN) and then I will describe how 
a CNN “learns”. Next, I will discuss the concept of transfer learning and the previous 
work that has been reported on fundus imaging (identified from the literature search 
presented in Chapter 3). 
4.2.1 Deep learning 
 
Deep learning was inspired by how humans process vision. Hubel and Weissel 
conducted pioneering studies that revealed how cells in the visual cortex of the brain 
are organised in layers where neuronal cells filter and respond (or fire) in the 
presence of different sensory information [154]. This process of accepting an input 
and applying an operation to output a response is the basis of a neuron that is the 
building block of an artificial neural network. The neurons are connected together 
(forming a network) and apply different operations to return an output that is a 
probability of the input belonging to a certain class. Figure 4.1 shows a mathematical 
neuron, labelled to illustrate the conceptual derivation from biology [155]. The value 
of a neuron is determined by the sum of the input weights with the addition of a bias 
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followed by a non-linear activation function which returns an output weight. An 
activation function is applied because the input could be any value. A sigmoid 
function is often used that scales this value between 0 and 1 [156]. Another popular 
method is an activation function called rectified linear units (Relu) that removes all 
negative values and changes them to zero [157]. The bias is a constant value that 
ensures the value of the neuron is never 0. All the weights, bias and outputs are 
learned during training of the neural network. 
 
Figure 4.1 A mathematical neuron that accepts multiple inputs (𝑤𝑤, weights) that are 
summed with the addition of a bias (𝑏𝑏). An activation function is applied to scale the 
output. The weights, bias and outputs are learned during training. 
The first layer in a neural network is convolution that gives a neuron its initial input 
weight. Convolution works by comparing images piece by piece (called a filter). 
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Convolution can be thought of as shining a spotlight of a certain size (i.e. a kernel) 
over an image (i.e. a sliding window) where the area that is illuminated (called the 
receptive field) is used to obtain information of that area. Figure 4.2 shows, as an 
example, classification of noughts and crosses [158] where a filter (i.e. features) 
already learned from the data (Figure 4.2B) are applied over the image that multiples 
the pixel in the filter with the corresponding pixel in the image (Figure 4.2B and C). 
The value is divided by the number of pixels in the filter returning a weighted sum 
that is stored in an activation map (Figure 4.2D). In this example, a diagonal kernel 
detects features with similar shape, and we can see this feature in the activation map. 
Figure 4.2E shows this process in terms of a neuron where the value of the filter 
response for each pixel is the weighted sum of inputs into a neuron. For every 
position of the filter over the image a value is returned. The value of the weights is 

















Figure 4.2 Example of convolution on noughts and crosses. A)  Image of either a 
naught or cross is input into the network that B) has learned features for classifying 
between the two. C) For example, the diagonal feature is compared to a section of 
the input image. The value in the same position in the feature (purple) is compared 
to the value in the same position on the input image (green). These corresponding 
feature pixels are multiplied over the whole feature and divided by the size of the 
feature. D) In this case, the value of the diagonal feature equals 1.00 and is recorded 
(filtering). This is then applied over the whole input image (convolution) producing a 
feature map. The activation of the diagonal feature can be seen in the activation map. 
E) This process is visualised in terms of a neuron. The value of the weights is from the 
weighted sum of the input with an activation applied and are stored as a neuron. In 
this case, we can see that white pixels have a large weight and results in the high 
activation value of the neuron. Effectively, there is a single neuron for every position 
of the filter on the input image. Concept and illustrations adapted from [158]. 
Usually the aim of a neural network is to classify inputs into predetermined classes. 
This may be assigned from a probability of an input belonging to a certain class. To 
progressively (i.e. through several convolutional layers) reduce the size of the output 
of a layer to a probability, pooling can be applied [159]. This involves walking a 
window of a specified size over the output of a layer and applying an operation. There 
are many operations that can be used, such as averaging the value of the window 
(average pooling) or taking the maximum value of that window (max pooling) [160]. 
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This results in a stack of smaller activation maps that still summarises the features of 
the data. By using repeating combinations of convolution, activation and pooling 
layers the output of each layer gets smaller and smaller [161].  
The final layers are usually fully connected (FC). The output of the final layer is an N-
dimensional feature vector, where N is the number of classes the network is 
classifying [161]. In the example of noughts and crosses N would be 2 since there are 
2 classes we are trying to classify. In Chapter 3, hand crafted features from the image 
(e.g. histogram-based features) were input into a classifier (such as an SVM) to 
categorise images into classes. Convolutional layers, in combination with activations 
and pooling layers, serve the same purpose as a feature extractor where the purpose 
of the FC layer is to interpret all these features into an output probability of an input 
belonging to a certain class. The FC layer introduces non-linearity by combining every 
output of the previous layer (i.e. “fully connected”) and applies an activation function 
to return an output probability. Many types of functions exist, but most common are 
sigmoid (binary classification) or softmax (multi-class classification), each aim to 
redistribute the output of the FC layer into a probability distribution (i.e. values 
between 0 and 1).  
Figure 4.3 summarises all of the layers and components of a basic neural network 
that have been discussed so far. In this example, the input is a cross that is passed 
through the convolution layer where filters are applied resulting in a stack of 
activation maps. In this simple network the activations are input into a pooling layer 
that results in stacks of smaller activation maps and this is repeated for another 
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convolutional and pooling layer. In the first convolutional layer, low level features are 
learned such as contrast or colour and edges. In the next convolutional layer high 
level features such as shape and contextual information is learned. This is because 
the activation maps of the input are progressively convolved to smaller images where 
more detail is preserved in earlier layers and become coarser in later layers. Finally, 
the activations of the previous pooling layer are all connected to the neurons in the 
FC layer that flattens the 3D volume into a 1D feature vector. In this example, the 
desired output is two classes, the value of which will be the weighted sum of the 
previous layer and is input into a softmax activation function to output a probability. 
When a cross is fed into the network, in the final FC layer there will be certain values 
that will be high and would contribute to a higher output probability for the input 






Figure 4.3 Components of a CNN for classifying noughts and crosses. A cross is input into the network and convolution is applied. The 
activations of a filter are output as an activation map and input into the next layer. This first layer learns low level features such as 
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colours and edges. The activations from this layer are input into a pooling layer followed by another convolutional layer. This is repeated 
where the output of the last pooling layer is flattened to a vector of neurons. The final FC layer consists of two neurons (corresponding 
to the tow classes). Finally, a softmax function is applied to redistribute the values to probabilities. This represents the likelihood 
(between 0 or 1) that the input image belongs to each of the classes. 
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How a neural network learns the values of the filters, weights and biases is called 
backpropagation and can be subdivided into 4 processes, the forward pass, the loss 
function, the backwards pass and weight update  [162]. 
When a network has been constructed, all values of the weights, biases and filters 
are set to random values (or initialised using a pretrained network, see Section 4.2.2). 
During the forward pass a training image is passed through all of the network layers 
and will output a probability. For example, if we placed a cross as the input image, 
the output of the FC layer could be 0.01 when we know that the output should be 1 
(i.e. a high probability that it is a cross). This gives an error and how it is computed is 
called the loss function. This function computes how well the model makes 
predictions given the current input compared to the correct output [163]. There are 
many loss functions and the choice of method largely depends on the data, presence 
of outliers and choice of learning algorithm [164]. Cross entropy is a popular loss 
function where the cross-entropy loss of prediction scores Y and training target T for 
number of observations (N) and number of classes (K) is given by, 
𝐿𝐿 =  − 1
𝑁𝑁
∑  𝑁𝑁𝑛𝑛=1 ∑  𝐾𝐾𝑖𝑖=1 𝑇𝑇𝑛𝑛𝑖𝑖 log(𝑌𝑌𝑛𝑛𝑖𝑖).  (4.1) 
This calculates the performance of the network and returns a probability between 0 
and 1 for each of the classes. Also called the log-loss, the value of the error increases 
as the predicted probability (Y) diverges from the true label (T). For example, a 
predicted probability of 0.01 when the true label is 1 would output a high loss value 
(L). A model with a perfect score would output a loss of 0. During training the loss is 
monitored, the higher the loss (i.e. the error) the further we are from the correct 
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answer. A decrease in loss during training is an assurance that the model is fitting and 
the network is learning. 
Once the error is computed a backwards pass is performed where the weights that 
contributed to the error are adjusted so that the error is minimised. This is achieved 
using gradient decent [165], an optimisation strategy that finds the best value of each 
weight that minimises the error and subsequently updates the value.  Figure 4.4 
explains the concept of gradient descent. As images are fed through the network, 
features and weights are constantly adjusted until patterns that occur in the data are 
learned. The size of this adjustment is called the learning rate. If you have many 













exist in a variety of forms. Over the years, more complex operations have been 
developed to model larger and more complicated datasets as they become available. 
Arguably, the driver of new network architectures is the benchmark ImageNet Large 
Scale Visual Recognition Challenge (ISLRVC) [166]. The challenge was to build a 
network that correctly classifies millions of natural images into 1000 categories. Early 
ImageNet winners produced networks such as AlexNet [161] and VGG [167] that 
were comprised of repeating convolution, normalisation and activation architecture. 
However, efforts to make these styles of networks deeper resulted in a new style of 
networks; Inception V2 and Inception V3 [168]. So-called due to their inception layers 
that deploy multiple convolutions, filters and pooling layers simultaneously and in 
parallel to the same layer. Recently, architectures containing residual layers have 
been developed whereby outputs from blocks of convolutions and normalisations are 
re-routed to the previous layer. This allows deeper networks to be trained such as 
ResNet [169] and can be combined with inception modules such as in Inception-
ResNet [168]. Xception is a newer architecture that is similar to an Inception model 
but maps multiple convolutional layers using residual connections [170]. More 
recently, networks have been used for semantic segmentation (assignment of every 
pixel in an image to a class) that follow an encoder (the pre-trained network) and 
decoder structure. A decoder semantically projects the features learned by the 
encoder back into the pixel space to obtain a per pixel classification. SegNet is a 
popular network [171] for semantic segmentation and is a VGG network (the 
encoder) followed with a decoder layer. The caveat is that these networks require 
large amounts of detailed pixel level annotations, which is difficult to obtain 
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especially in a healthcare setting due to time-constraints and data governance issues 
such as patient anonymity. 
4.2.2 Transfer learning 
 
Transfer learning has become a popular method, particularity in medical image 
analysis, whereby a pre-trained model is reused for a new task, requiring only small 
amounts of data [151]. In early layers of a neural network basic features such as 
colour and shapes are learned (see Figure 4.3). In transfer learning the early layers 
and their weights can be used as a feature extractor and new FC layers are trained 
for a new purpose (so-called fine tuning). This is on the basis that early learned 
features will be similar across imaging domains. For example, the colour green is still 
the colour green in the training set and the transfer learning set.  The number of 
layers that are used as feature extractors (i.e. the number of trainable layers) can also 
be experimented with to optimise the network.  
As neural networks apply operations with a specific size parameter, input images 
must also be the same size. Typically, pre-trained networks have input sizes of 
224×224 pixels, 299×299 pixels and 512×512 pixels. Such predefined sizes have arisen 
due to the memory and computing power that is required to perform multiple and 
complex operations on an image. The larger the image, the more computational 
power is needed to learn features, as well as a deeper network. The first step in 
training a network involves resizing all images. Image normalisation is performed to 
make all images have the same data distribution. There are three common 
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techniques that involve either normalising values of the image (1 to 255) from 0 to 1, 
or values from -1 to 1 or to centre values around mean. The normalisation technique 
and the input size adopted depends on the data used to originally train the network. 
In Figure 4.4, the gradient decent algorithm is searching to minimise a loss function 
to find the optimum value of the weight that minimises the error and was shown in 
2-dimensions because this can be easily visualised. In practice, the value of all weights 
must be made in the many dimensional space of weights and biases. This can be 
visualised in 3-dimensons where the x-axis is the value of weight 1 in layer 2 and the 
y-axis is the value of weight 2 in layer 3. The z-axis is the value of the loss for a value 
of the two weights. The aim is to find the values of the weights at the minimum of 
the loss function and uses gradient descent to search for the minima, as before. 
However, if there are large amounts of variation within the data this can lead to 
differently varying shape of the loss surface between dimensions. For example, 
weight 1 on the x-axis could vary on a scale of 0 to 1, while weight 2 on the y-axis 
could vary on a scale from 0 to 0.001. Figure 4.5 shows the loss surface shape as a 
contour plot next to the visual representation of the gradient descent search along a 
loss function to visualise the reasoning for image normalisation upon input into a 
neural network. It shows an uneven loss topology due to the different scales on the 
x -axis and y-axis and the arrows indicate the search direction to reach the optimal 
weight value (asterisk). In Figure 4.5B we can see how this looks in relation to 
updating the weight to minimise the error. The drastic updates in the weight value 
due to the large differences between the weights has caused an overshooting of the 
optimal weight value. When the x-axis and y-axis are normalised to a range from 0 to 
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1, the weight parameter is updated in even proportions (Figure 4.5C) and the search 
along the loss function is less drastic and leading to a better convergence of the 


















Figure 4.5 Visual representation of the concept of image normalisation upon input 
into a neural network in relation to the loss function, gradient descent and 
converging weight values to minimise the error in the loss function. The asterisk 
denotes the optimum weight value. A) Loss surface as a contour plot with the search 
path of gradient descent (i.e. learning rate). The topology is elongated due to the 
different scales on the x-axis (0-1) and y-axis (0- 0.001). B) Visualisation of the 
gradient descent search path along the loss function. The drastic weight updates due 
to the uneven loss topology cause the optimum weight value to be overshot. C) Loss 
surface following image normalisation creates an even loss surface. D) Weights are 




To utilise the already learned features from a pre-trained network the learned 
weights must be fixed, termed frozen. Any number of layers can be frozen but 
traditionally all weights in the convolutional layers are frozen and the weights of the 
FC layers are initialised from their trained weights. The ImageNet dataset is a popular 
dataset used to train many networks where the final FC layer contains a classifier for 
1,000 categories [166]. This can be replaced with an FC layer of a specific size. Drop 
out layers are commonly placed between FC layers which randomly sets inputs to 0 
with a given probability and prevents the network from overfitting [172].  
 In transfer learning the whole dataset is passed through the network and only the 
weights of the final FC layers are adjusted. Each pass of the dataset through the 
network is called an epoch and the dataset can be passed in batches to minimise 
computing time. The processing of a single batch is called an iteration. A portion of 
the dataset is usually held out as a validation set to test over a certain number of 
iterations or epochs. During training, the loss and other performance metrics such as 
accuracy can be monitored to assess neural network performance. Neural network 
design, training and optimisation is a cyclic process. This involves training the 
network, adjusting architectures, loss functions, learning rates and classification 
functions along with their hyperparameters and retraining the network. This process 
is used to achieve a network design that optimises learning on the dataset. 
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4.2.3 Previous work 
Deep learning and transfer learning have proved successful in many medical images 
including fundus imaging [173][174][48][175] and OCT [176][177] and have rapidly 
become key methods for medical image analysis [152][151]. The following articles 
discussed in the following section were identified in the literature search described 
in section 3.2.3. 
Tan et al [173] implemented a 14-layer CNN to classify 1,110 fundus photographs as 
disease or no disease and achieved an accuracy of 95.25%. Burlina et al [178] used 
transfer learning of the Overfeat CNN [179] to classify 5,600 fundus photographs into 
their AREDS categories [134]. They achieved a 92% to 95% accuracy where best 
performance was between class 1 and class 4 AMD severities. The same experiment 
was performed in their later work where the Overfeat CNN features were used to 
fine-tune an SVM classifier to classify 5,664 images [174]. They reported best 
performances of 79.4%, 81.5% and 83.4% to classify images into AREDS classes 4, 3 
and 2 respectively. Grassman et al [175] used transfer learning of multiple ImageNet 
CNN’s [180][181][161][168][170] to classify 120,656 fundus photographs into AREDS 
categories [134]. They built a so-called ensemble of CNN’s where the predictions 
from each network were combined into a mean prediction. They achieved an 
accuracy of 92.1% for predicting each AMD class. They tested their ensemble on an 
independent dataset of 5,555 fundus photographs [136] and achieved an accuracy of 
34%. The low accuracy was attributed to the presence of younger eyes in this dataset 
that had dominant macular reflexes (brightly appearing artefact from the flash of the 
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fundus camera) that was misclassified as stage 4 AMD (i.e. misclassified as containing 
GA). Peng et al [182] used an ensemble of 3 neural networks (called DeepSeeNet) 
designed to first classify 3 categories of drusen (small/none, medium and large) then 
a sub network to classify pigment abnormalities (hypopigmentation or 
hypopigmentation) and a final network to detect the GA (neovascular AMD or central 
GA). Their training and testing sets contained 58,402 and 900 fundus photographs 
respectively, with annotations for each of the classes from two retinal specialists. The 
overall aim was to address the challenge of classifying fundus images into the AREDS 
categories by detecting each pathology that defines the AMD classes.  They achieved 
a 72% accuracy (71% sensitivity, 71% specificity) for classifying drusen subtypes, 89% 
accuracy (73% sensitivity, 95% specificity) for classifying pigmentary changes and 96% 
accuracy (62% sensitivity, 98% specificity) for classifying GA subtypes. The source of 
misclassifications came from image quality such as bright artefacts that were 
classified as GA. 
Inspired by the direction of the field described here along with recent advances in 
deep learning and transfer learning and its success for solving medical image analysis 
tasks, a neural network approach for detecting drusen in UWF images was adopted 





4.3 Materials and methods 
 
4.3.1 Training dataset 
 
For a human grader, manually identifying drusen is a subjective and challenging 
process, particularly in UWF images, as drusen are difficult to distinguish from the 
background texture of the retina. Training a neural network using ambiguous 
examples or single drusen (which could be one pixel in size) would be difficult 
because there would not be enough examples of distinguishing features making the 
problem too complex and near impossible for the network to solve. To simplify the 
problem, the network was trained using clearly recognisable examples of patches 
positive for drusen and negative for drusen that I selected. Such patches were 
obtained from images of people with early AMD where drusen are often clearer and 
higher in abundance than elderly people with AMD or those without disease.  
The training set consisted of 25 patients with early AMD (14 left eyes, 15 right eyes) 
and 20 patients with age related drusen all acquired with a UWF SLO (Daytona, Optos 
plc, Dunfermline, UK) and diagnosed by ophthalmologists. Patient information such 
as gender, age and ethnicity were not available. All images were converted to a 
stereographically projected format to allow the curved retina to be displayed as a flat 
image using a tool provided by Optos [74]. From the training set, I selected positive 
image patches (513 total). A patch was considered positive if it contained 
unmistakable drusen. In order to obtain a balanced training set of positive and 
negative examples, 407 negative image patches were randomly sampled from 16 
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patients with age-related drusen and a further 106 manually selected from the 25 
UWF images with early AMD (513 total). Figure 4.6 shows examples of positive and 
negative patches. 
Figure 4.6 Examples of positive and negative patches. Patches were 122×122 pixels, 
224×224 pixels or 299×299 pixels in size depending on the object being sampled (i.e. 
smaller single drusen in smaller patch or drusen clusters in larger patches) Positive 
patches included drusen clusters (top left) and larger forms of drusen (top left). Single 
druse (middle left) and single druse near vessels (middle right). Drusen also appear 
near the optic disc (OD) (bottom left) or are sometimes obscured by eyelashes 
(bottom right). Negative patches included healthy retina (top left) and healthy retina 
near the image border (top right). Regions near the OD where bright nerve fibre layer 
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(NFL) could also look like drusen (middle). Potential false positives such as specs of 
dust (bottom left) and eyelashes that have inadvertently been captured in the image 
(bottom right) were also sampled. 
4.3.2 Training 
 
VGG16 architecture, a well-established architecture for image classification [167], 
was fine-tuned using transfer learning (ImageNet weights [166]) by retraining the 
final FC layer. The VGG16 architecture consists of 13 convolutional layers (3×3 pixels), 
5 max pooling layers (2×2 pixels) and 3 FC layers and was originally trained to classify 
non-medical images into 1,000 classes (such as cats, dogs, flowers etc) [167]. To avoid 
overfitting, a drop out layer (p = 0.5) [172] was inserted following the 4,096 neuron 
fully connected layers. I replaced the final 1,000 neuron fully connected layer with a 
2-class softmax classifier (2 neurons) and trained using stochastic gradient descent 
with a cross entropy loss and a learning rate of 0.01. Figure 4.7 shows the VGG16 








Figure 4.7 VGG16 Network Architecture. VGG16 accepts 224×224 pixels size images 
into the network. Convolutional layers (grey layers) transform the image into stacks 
of features. Max pooling shrinks the convolution by taking the maximum value in a 
2×2 pixel sliding window on the convolution output. Fully connected layers (pink 
layers) outputs a two-dimensional vector that is the probability that the input was 
either negative or positive for drusen. To avoid overfitting, a drop out layer (blue 
layers) was inserted following the 4096 neuron fully connected layers.  
Each image was resized to 224×224 pixels to conform with VGG16 required input size 
and normalised by subtracting the mean intensity of the training set from each pixel 
[161]. The network was trained for 100 epochs and was stopped when the loss no 
longer decreased. To increase training set size and variability, data augmentation was 
performed during training by applying rotation to the training patches at random 
intervals of 0 to 45° and shearing by 45°, separately (see Figure 4.8). Rotation 
augmentations are important especially in the case of patches containing vessels. If 
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there are a high number of patches containing horizontal vessels the network may 
learn vessels as a distinguishing feature. To minimise such scenarios, rotations 
provide different orientation of objects and shearing provide different distortions of 
the image and creates more examples for the network to learn from. This increased 
the training data to a total of 5000 patches. During training, the dataset set was 
randomly shuffled leaving 25% of the dataset (including augmented images) out for 
validation every 179 iterations. 
 
Figure 4.8 Example of different augmentations applied to an image patch containing 
drusen. Shear (B) and random rotations (C).  
4.3.3 Testing dataset 
 
The validation dataset consisted of 244 images (199 left eyes, 120 right eyes) of 
individuals graded for AD, Posterior Cortical Atrophy (an AD subtype) and healthy 
controls. Images were acquired on an Optos P200Tx (Optos plc, Dunfermline, UK), 
provided by Dementia Research Centre, University College London with drusen 
annotations from the Queen’s University Belfast, Belfast. Individual image disease 
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status as well as patient information was not available. All images were 
stereographically projected [74]. 
4.3.4 Testing 
 
Two trained observers with expertise in UWF retinal image annotation and 
histological imaging (referred to as Observer 1 and Observer 2) had manually graded 
the testing set independently, subdividing each image using the Manchester grid 
overlaid onto the UWF images [183] (see Figure 3.9). This approach divides the image 
into cells with each cell containing an area equivalent to that occupied by the OD (i.e. 
1.77mm2). This results in 764 cells of equal area on the retina but with different 
proportions when viewed on the flattened image. The cells were indexed with x- and 
y- coordinates and an origin at the fovea (0,0). In order for each cell to be compatible 
with the neural network input layer, patches were geometrically transformed by 
linear interpolation to 244×244 pixels using a tool provided by Optos. Some 
peripheral cells were too elongated for this transform and had to be discarded (416 
cells outside the periphery zone (blue) in Figure 4.9). This left 348 cells per image but 
which adequately covered the posterior pole and peripheral retina. These were the 
cells annotated as either drusen positive or drusen negative by the two observers. To 
assess the performance of the drusen detector in different regions of the image, cells 
were grouped into three zones; periphery, perimacular and central - according to a 
simplified grid previously used for grading AMD [184], as highlighted by the different 
colours in Figure 4.9. The first zone defines the central region of the retina and 
consists of 16 cells (magenta; 28.32mm2). This zone typically has a high proportion of 
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pathology in AMD and covers the early treatment diabetic retinopathy study (ETDRS) 
grid commonly used to report retinal thickness in neurodegeneration [185]. The 
second zone defines the perimacular region of the retina and consists of 76 cells 
(green; 134.52mm2). The final zone defines the peripheral region of the retina and 
consists of 256 cells (purple; 453.12mm2). Areas outside the peripheral zone were 
often labelled as ungradable by the observers due to the appearance of eye lashes 
and eye lids in the images. Lashes and lids are difficult to avoid at image acquisition, 








Figure 4.9 The Manchester grid (white lines) overlaid onto a UWF image showing cells 
grouped into zones. Zones are defined as 3 circles centred on the fovea.  
The output of the classification by the network was then compared to the manual 
annotations by two human observers. As manually grading drusen in UWF images is 
a challenging process, the union of the 2 observers (UObs) was also considered as a 
means of assessing performance in the context of low inter-observer agreement. 
Cells were binarized for drusen labels and used to compare the agreement between 
the two observers by calculating a Dice Similarity Coefficient (DSC). The DSC is 
calculated using the binarized image of annotations and is calculated as 2 times the 
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area (in pixels) overlap (or intersection) of the two observers divided by the total 
number of white pixels in both of the binary images and is a quantitative measure of 
performance. Figure 4.10 shows the binarized images, the union and intersection of 
manual annotations by the human observers. 
 
 
Figure 4.10 Examples of binarised annotations on the MG by Observer 1, Observer 2, 
union of the Observers (UObs) and intersection of Observers, used to assess 
performance. The union is defined as all cells labelled positive for drusen, whereas 
the intersection is defined as only the cells the observers agreed to contain drusen. 
A true positive (TP) was an instance or cell predicted as positive for drusen by the 
system and annotated as drusen by the human observer. A true negative (TN) was an 
instance predicted as negative for drusen and annotated as not drusen by the human 
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observer. A false positive (FP) was an instance predicted positive for drusen but 
annotated manually as not drusen. A false negative (FN) was an instance predicted 
as negative for drusen but is annotated manually as drusen. According to these 
definitions, the following formulae can be applied to obtain metrics that quantify 
system performance - sensitivity, specificity and accuracy. 
• Sensitivity = (TP/(TP+FN)) x 100    (4.2) 
• Specificity = (TN/(TN+FP)) x 100    (4.3) 
• Accuracy = ((TP+TN)/(TP+TN+FP+FN)) x 100  (4.4) 
 
Additionally, the area under curve (AUC) receiver operator characteristic (ROC) can 
be used to measure the relationship between sensitivity and specificity and is 
calculated by thresholding using the probability returned by the system. The 
probability indicates the degree at which the instance or cell belongs to a certain 
class. A curve plotting 1-specifity against sensitivity is created by varying this 
threshold and summing the area under the curve. Sensitivity and specificity were 
calculated for each image using both Observer 2 as the reference and Observer 1 as 
reference and compared using non-parametric Mann-Whitney U test. 
Observer agreement was assessed using Cohens Kappa coefficient (κ) a well-
established technique for comparing binary gradings [186]. Figure 4.11 shows how κ 







Figure 4.11 Interrater agreeability assessment using Cohens kappa coefficient (κ). The 
counts of agreed annotations (a and d) and the counts of disagreed annotations (b 
and c) are totalled for each image over the set to obtain kappa score, standard error 
and 95% confidence intervals. A perfect Kappa score is 1 whilst an agreement by 
chance is 0 [186]. 
4.4 Results 
 
4.4.1 Inter-observer agreement 
 
The calculated Kappa score indicated a moderate agreement between the observers 
(κ = 0.53). Figure 4.12 shows the number of cells annotated for drusen in each zone 
by each observer, where a lower abundance of drusen was observed in the central 
zone compared to the periphery and perimacular zones. Observer 1 annotated a total 
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of 262 cells as continuing drusen in the central zone compared to Observer 2 who 
annotated a total of 213 cells with drusen. In the perimacular zone, Observer 1 
annotated 1,234 drusen cells while Observer 2 annotated 1,216 drusen cells. 
Observer 1 annotated a total of 3,216 drusen cells in the periphery zone compared 
to Observer 2 who annotated 3,406 cells as drusen. Thus, it appears as if there was a 
good inter-observer agreement. However, the DSC calculation points to a low level 
of agreement (average DSC 0.38, SD± 0.27) suggesting that the observers do not 
agree particularly well on exact cell locations for drusen. 
 
Figure 4.12 Histogram of the total number of cells annotated for drusen by Observer 
1 (Obs1) and Observer 2 (Obs2). 
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Cells where observers disagreed on the presence of drusen were visually assessed 
and were placed by me into 2 categories: ambiguous and low quality. Figure 4.13 
shows examples of cells from both categories. Ambiguous cells contained subjective 
drusen, dust or non-obvious lesions in the retina. The low quality contained cells that 
were difficult to discern where the drusen were located due to poor image quality 
and low contrast. 
 
Figure 4.13 Examples cells where observers disagreed. In each category the white 
arrows indicate possible drusen A) Ambiguous patch that contains areas that could 
be subtle drusen or the texture of the retina (white arrow). This would be a subjective 
decision as to whether to manually label as drusen or not. B) Low quality cell that 
contains potential drusen or artefact (white arrow). 
Figure 4.14 shows an example of the gradings from the 2 observers overlaid onto an 
UFW image. This revealed that where drusen were prevalent there was a higher level 
of agreement between observers on location.  Disagreement seems to occur when 
drusen overlap into neighbouring cells with one observer annotating the neighbours 
as containing drusen while the other observer may not. In images where drusen are 
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sparsely located there was less of an agreement between observers on location. This 
corresponded to ambiguous cells. 
 
Figure 4.14 Examples of gradings by Obs1 (blue) and Obs2 (pink) and where they 
intersect (white) in an image with sparse drusen and low agreement (left) and an 
image with an abundance of drusen and high location agreement (right). It can be 
seen that much of the disagreement occurs around the main body of drusen clusters 
where overlaps of drusen into neighbouring cells occurred. 
 
4.4.2 Neural network performance 
 
The neural network, called the drusen detector (DD), trained to a 95% validation 
accuracy. The drusen detector returned a slight agreement (κ = 0.17) to Observer 1, 
a fair agreement to Observer 2 (κ =0.21) and a slight agreement (κ = 0.17) to the 






Using Observer 1 as the reference, the area under a ROC curve (AUC) for detecting 
grid cells with drusen was 0.59, 0.62 and 0.65 in the central, perimacular and 
peripheral zones respectively. Using Observer 2 as the reference, AUC was 0.58, 0.65 
and 0.66 in the central, perimacular and peripheral zones respectively. Figures 4.15 
and 4.16 give a graphical representation of this data. 





Figure 4.16 ROC curves within each zone for the drusen detector using Obs2 as 
reference. 
I visually inspected false negatives and false positives for the DD system to assess the 
source of these types of errors and some examples are shown in Figure 4.17. False 
positives seemed to occur in bright areas near blood vessels and the OD, as the 
contrast or brightness seems to resemble that of drusen. This was also a source of 
false negatives, as subtle drusen can look like these types of bright areas near blood 
vessels and the OD. Areas of low quality, subtle drusen and ambiguous patches were 
a source of false negatives as drusen were difficult to discern from the background 
retina. Artefacts at the image border such as the reflection from the faceplate and 
dust were a source of false positives (specs of dust are bright in appearance and look 
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like drusen). However, some cells identified as false positives contained drusen and 
indicated some human error in the manual grading process. 
 
 
Figure 4.17 Examples of cells that were false positives and false negative returned by 
the drusen detection system. 
To assess how performance of the drusen detector varied with increasing agreement 
between the two observers, each image was binned according to the DSC of Observer 
1 (using Observer 2 as reference) and Observer 2 (using Observer 1 as reference) at 
0.1 intervals and plotted against AUC (see Figure 4.18). The best performance for the 
drusen detector was observed in 8 images (DSC > 0.8 and < 0.9) achieving AUC 0.84 
for all zones 45.5% and 46.3% sensitivity (in relation to Observer 1 and Observer 2 
respectively) and 99.9% and 97.2% specificity (in relation to Observer 1 and Observer 
2, respectively). An AUC of 0.85 and 0.82 was achieved in the peripheral zone (in 
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relation to Observer 1 and Observer 2 respectively), an AUC of 0.82 and 0.78 in the 
perimacular zone (in relation to Observer 1 and Observer 2, respectively) and an AUC 
of 0.55 and 0.59 in the central zone (in relation to Observer 1 and Observer 2, 
respectively). 
 
Figure 4.18 Dice Similarity Coefficient (DSC) from Observer 1 (using Observer 2 as 
reference (blue; Obs1)) and Observer 2 (using Observer 1 as reference (purple; Obs2)) 
of each image binned into intervals of 0.1, against the drusen detector performance 
(AUC) of each bin. The number of images within each DSC interval is displayed on the 




Figure 4.19 shows the output of the drusen detection in the 8 UWF images with the 
highest AUC. The predictions are colour coded as a ‘heatmap’ and overlaid onto the 
UWF image. Observer 1 annotations (pink) and Observer 2 (blue) and their 
agreement (white) are also displayed. Cells with a high probability for containing 
drusen and good observer agreement were visually inspected and observed to 
contain hard and soft drusen clusters. These cells had a similar appearance to the 
positive image patches used to train the network. Visual inspection of cells with 
observer disagreement (either blue or pink), which appear around the edges of high 














Figure 4.19 Comparison of Observer annotations. White denotes agreement 
between observer, blue denotes the annotations of Observer 1 and pink the 
annotations of Observer 2 Dice Similarity Score (DSC) for the observers is also given 
where a higher number denotes better agreement. The output of the automatic 
drusen detector is a probability map (white high probability drusen (1) to black low 
probability drusen (0)) which has been colour coded and overlaid onto the images. 
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Two images had a DSC of 0.98 and 1.0 where the drusen detector performed at 0.41 
AUC. These images were visually inspected and contained exceptionally sparse and 
subtle lesions surrounding the OD and in areas of low quality due to shadows from 
lashes. This suggests that the reason for the low AUC was due to the drusen detector 
failing to identify small and subtle lesions, whereas both human observers were able 
to classify these instances. One false positive was observed on the OD in one of the 
images (DSC = 1.0) which contained round and bright drusen like shapes and is shown 
in Figure 4.20. In order to assess the nature of the potential pathology the 
accompanying autofluorescent image was inspected to identify any possible OD 











Figure 4.20 Visual inspection of the source of low performance in an Image with DSC 
of 1.0 and AUC 0.41. A) Output of the drusen detector shows high probability cells 
for drusen near the OD but were false positives (yellow and white) and also contains 
false negatives near the vessels (pink). B) Visual inspection of the false positives and 
false negatives in the green channel. The false negative (green box) shows regions of 
very subtle drusen around the vessels. The false positive (magenta box) contains 
bright drusen like shapes in the OD that looks like it could contain OD drusen. C)  




I have presented a transfer learning-based system for the automatic detection of 
drusen in UWF images. Key aspects of the system included: the training of a neural 
network using a small number of images; performance assessed against two human 
observers; network specificity similar to that of the observers. 
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Specificity remained high in all zones indicating the network’s ability to classify 
negative instances. This would be beneficial in a clinical environment, particularly for 
screening for signs of neurodegeneration, as the number of false positives would be 
low which would reduce the number of patients being incorrectly referred for further 
examination. Sensitivity was higher when inter- observer agreement was high and 
suggests that when the reference standard is reliable the system performs similar to 
a human observer. However, this was with the exception of two images which had a 
low AUC for the automatic detection when agreement was highest and was due to 
the difficult appearance of drusen that were only several pixels in size. This would be 
a challenge for a neural network to learn/detect but annotated readily by the two 
graders who had expertise in histological analysis of drusen and would have the 
ability to assess for drusen in a UWF image in the context of molecular composition 
and how drusen may be contorted within the layers of the retina.  
One image had perfect agreement between observers (DSC = 1.0) and second image 
near perfect agreement (DSC = 0.98). The DD performed at 0.41 AUC for these 
images. After visual inspection it was seen that the images contained a low 
abundance of subtle and small drusen, which represents a difficult classification task 
for the proposed system. However, the average DSC was low for the whole dataset, 
suggesting that the observers disagreed frequently on exact locations of drusen. A 
common source of disagreement occurs when drusen overlap into cells, where one 
observer might annotate the neighbouring cell as containing drusen but the other 
does not. The cell annotated within the overlap might only contain drusen a few 
pixels in size, which would also be a difficult instance for the drusen detector to 
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classify. Another source of disagreement was from regions of soft drusen that are 
inherently ambiguous due to their similarity in appearance to the texture of the 
surrounding retinal tissue. Standardisation of the conditions in which grading is 
conducted (i.e. training, background room lighting and computer screen size) may 
help to improve observer agreement. Additionally, dust and vitreous material were 
also present in some images and can resemble drusen, further contributing to 
observer disagreement and drusen detector misclassification. To minimise dust 
artefacts at least, the UWF optics can be cleaned in line with the manufacturer’s 
guidelines for device care in order to remove particulates prior to image acquisition. 
The use of heatmaps to visually inspect the predictions were insightful for visualising 
the output of the neural network and could have application for monitoring drusen 
progression and changes in longitudinal images. Drusen progression could then be 
quantified by change in drusen distribution and area from the probability map and 
used to investigate new biomarkers or associations between drusen and 
neurodegeneration. 
The drusen detection system is likely to be improved by training the network with 
more image data and also additional observers to create a more consistent reference 
standard. In previous work using deep learning (discussed in section 4.2.3) for 
classifying AMD severities involved training neural networks with approximately 
5000 - 120,000 images achieving accuracies above 70% where performances varied 
depending on the dataset (i.e. presence of artefact or low-quality images). 
Comparable to the work in this thesis, Peng et al [182] used 58,402 fundus 
136 
 
photographs for training and 900 for testing, achieving 72% accuracy (71% sensitivity, 
71% specificity) for classifying drusen subtypes, 89% accuracy (73% sensitivity, 95% 
specificity) for classifying pigmentary changes and 96% accuracy (62% sensitivity, 98% 
specificity) for classifying GA subtypes from whole fundus photographs. The 
performance was compared to the image gradings obtained from 88 readers in  the 
AREDS study for classifying AMD severity [134]. Observer agreement in the AREDS 
dataset for drusen presence, type and area gradings in 1,230 eyes gave kappa scores 
of 0.50, 0.61 and 0.56, respectively [187]. This is comparable to the observer 
agreement in this chapter (kappa = 0.53) further highlighting the challenging nature 
of manually grading for drusen. It also suggests that while more training data would 
improve the system a more reliable reference standard is still required. Drusen are 
subjective to grade and is the main reason for the low observer agreement. This 
highlights the need for precise drusen grading protocols that minimise the 
subjectivity to provide a reliable reference standard to validate (or train) an 
automatic system against. Such grading protocols would need to be designed so that 
annotations can be input into a neural network (e.g. coordinates or patches) and 
follow grids outlined in this chapter. Such grading methods would be manually 
intensive, time consuming and expensive. Given the presence of these challenges, 
the recommended number of additional training data that would most likely see an 





The aim of this chapter was to develop a method to automatically detect drusen in 
UWF images, validated to a reference standard and assess its utility for application 
for future assessment of neurodegeneration in UWF images. Bearing in mind the low 
sensitivity, this system will be used in an exploratory analysis of the dataset described 





















In this chapter the analysis of a cohort featuring patients with MCI and AD as well as 
CH individuals is reported. Vessel analysis was performed using a previously 
established pipeline and is described. Objective features of the retinal vasculature 
including vessel widths, vessel tortuosity and branching complexity (measured via 
fractal analysis) are analysed using statistical modelling that accounts for the 
correlation between two eyes of an individual in order to assess evidence of 
differences between the cohort sub-groups. The aim is to investigate potential 
biomarkers of pre-clinical AD derived from the retinal vasculature in a UWF image.  




This cross-sectional study featuring patients with MCI and AD as well as CH individuals 
was accessed via Duke University School of Medicine (Durham, North Carolina, USA). 
Participants were aged 50 or older and were enrolled in a study from the Duke 
Memory Disorders Clinic. All participants were appropriately consented following 
local rules and procedures pertaining to ethical approval and clinical research 
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governance, which included permission to share anonymised data for analysis in this 
thesis. AD and MCI participants were evaluated and diagnosed by an experienced 
neurologist with a specialisation in memory disorders. Assessment was based on the 
diagnostic guidelines of the National Institutes on Aging-Alzheimer’s Association 
[188] [189]. In these guidelines, MCI is the term used to describe presymptomatic AD. 
MCI was identified by: assessment of change in cognition in comparison to a person’s 
previous cognitive ability; impairment in one or more of memory, executive function, 
attention, language and episodic memory; problems with performing everyday tasks 
such as paying bills and not demented (i.e. cognitive changes significantly mild that 
they have no impaired social or occupational functioning) [189]. AD was identified in 
individuals in a similar fashion and were differentiated from MCI by an expert 
clinician on whether symptoms have significant interference with their ability to 
function at work and in everyday activities [188]. Participants did not undergo PET or 
CSF assessment to determine pathology or biomarker status. CH individuals were 
recruited from either the spouses of the patient volunteers or from the Joseph and 
Kathleen Bryan Alzheimer’s Disease Research Centre that includes a database of 
cognitively normal individuals based on extensive testing including MoCA [32]. 
Exclusion criteria included non-AD dementia, diabetes, uncontrolled hypertension, 
demyelinating disorders, glaucoma, AMD and other vitreoretinal pathology that 
could interfere with the retinal image analysis. MMSE [190] was used to evaluate 
cognitive function on the same day of image acquisition. An Optos California UWF-
SLO was used to image the retinal vasculature of 169 participants. Both left and right 
eyes were imaged where possible (212 CH, 62 AD, 64 MCI images). An additional 9 
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CH (3 left, 6 right), 4 MCI (3 left, 1 right) and 8 AD (2 left, 6 right) single eyes were 
obtained where images from both eyes was not feasible (e.g. challenges during image 
acquisition).  
120 of these images were rejected (102 CH, 16 MCI, 2 AD) due to malfunctioning of 
the device thought to be an error in the detector. The detector is an avalanche 
photodiode (APD) which is responsible for converting light to electricity. There are 
two APD’s in the device, one for the green laser to convert to the green channel in 
the image and one for the red laser to convert to the red channel in the image. Error 
in APD functioning would cause noise in the conversion of either channels. In this 
study, the green APD was the most likely cause of the malfunction as the noise was 
in the green channel. Figure 5.1 shows images with varying levels of detector error 
that occurred in the dataset. The result was a noisy green channel that obscured 
retinal landmarks including the vasculature and so measurements were not possible 
to obtain in these images. 
 
Figure 5.1 Example images displaying varying severity of detector error from low to 
high (left to right).  
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16 images were rejected due to obstruction of the OD or fovea (6 CH, 10 AD) which 
occurs when eyelashes, eye lids, retinopathy or media opacity are present in the 
image obscuring these landmarks (Figure 5.2), which are needed for the vessel 
segmentation process. In addition, media opacity reduces the definition of the 
vasculature and vessel segmentation would be unsuccessful for these images. 
 
Figure 5.2 Examples of images with obstruction of the OD and fovea by eyelashes and 
eyelids (left), retinopathy (middle) and media opacity (right). Images such as these 
were rejected because vessel segmentation and the subsequent measurements 
would be unsuccessful in the analysis pipeline. 
Images were exported from the device in non-compressed TIFF format to preserve 
detail. Images were sent for stereographic projection (see Chapter 2) and returned 
with the projected image along with a .txt file with the projection error recorded. This 
automatic process was made available by Optos. If the projection error was >1 the 
image was rejected as the projection process that allows pixel measurements of the 
vasculature to be converted to mm equivalents but would not be precise from such 
inaccurate projections. Projected images with a large error usually occur due to 
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incorrect automatic fovea detection in the Optos process arising either from 
retinopathy or from poor image quality. Manual identification of the fovea can be 
used to reduce the projection error. This was not performed in this dataset because 
the incorrectly projected images had no green channel, possibly arising from the 
error in the detector. 16 images were rejected due to unacceptable projection errors 
(6 Control, 8 MCI). Figure 5.3 shows an example of a successful (left) and unsuccessful 
projection (right). Following data cleaning 107 CH, 42, MCI and 60 AD images were 
sent for segmentation of the vasculature. 
 
Figure 5.3 Shows a successful stereographically projected image (left) and an 







5.2.2 Vessel segmentation and correction 
 
The vessel analysis procedure involved: (1) definition of a ROI, (2) automatic 
segmentation of the retinal vasculature [191], (3) manual correction of the 
segmentation, (4) labelling of arteriolar and venular vessels [192] and (5) extraction 
of vasculature measurements pertaining to the vasculature [191][117]. 
To obtain an optimal segmentation of the vasculature, a ROI was manually defined 
first in order to select an area free from eyelashes, eyelids and artefacts (Figure 5.4 
A-B). This produced a mask that maximises the usable FOV (typically larger than is 
available from a conventional fundus camera) whilst minimising any features that 
could lead to incorrect segmentation. In some occasions, due to suboptimal 
participant positioning during image acquisition, bright reflections occur in the 
perimacular zone (see Chapter 4 for the definition of this zone) (Figure 5.4 A). Such 
artefacts may be incorrectly segmented as vessel but can be removed in a manual 
correction stage. Within the ROI, a binary map of the vascular network was obtained 
from pixel-wise classification (assigns probabilities to pixels) by a previously 
developed fully connected neural network with a reported AUC 0.97 [117] (Figure 5.4 
C). Some smaller vessels fail to segment, a common limitation of retinal vessel 
segmentation techniques, or parts of the vasculature were obscured by eyelashes 
that could not be avoided in the ROI selection stage and so were not segmented 
correctly. The segmentation may also contain inaccuracies due to complicated vessel 
junctions and crossings as well as intertwining arteriolar and venular paths. To 
simplify the vascular network, a skeletonised version of the binary vessel map was 
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created. This was used to represent the network as a graph structure where the 
edges are vessel paths and the nodes represent either the start/end of a vessel or a 
vessel bifurcation (Figure 5.4 D)[117]. 
 
Figure 5.4 Output of the preparation and segmentation stages to vessel analysis in 
UWF [117]. (A) The OD and fovea are manually located as landmarks (red cross). A 
ROI is defined by either placing a resizable ellipse onto the image or by selecting 5 
points around the ROI to create a tilted ROI. It can be seen in this image that a dark 
artefact exists in the right portion of the image and could not be avoided. (B) The 
resulting ROI binary mask. (C) The automatic segmentation within the ROI performed 
by the neural network. (D) The skeleton of the segmentation is displayed over the 
image for a manual correction stage that aims to obtain the most accurate 
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representation of the vascular network as possible by allowing a user to make a 
limited set of corrections. 
 
To ensure that the vascular network is as accurate as possible, I completed a manual 
correction step. A vessel tree is represented as one vessel path that extends from the 
OD to the periphery. The aim was to create complete and fluent vessel trees to allow 
a comprehensive set of valid measurements to be extracted. The type of corrections 
that were enacted are (A) completing trees, (B) identifying vessel crossings, (C) 
removing false positives such as those that arise from retinopathy or artefact, and 
(D) untangling complicated network patterns.  
The following descriptions refer to Figure 5.5. 
Correction of type A were needed when either a reduction in image quality (i.e. a 
reduction in contrast) occurs along a vessel that leads to suboptimal segmentation, 
or from artefact that prevents accurate segmentation and breaks the vessel path 
(Figure 5.5 (left) 4, 6 and 9). These can be time-consuming corrections to make as 
UWF imaging captures a large amount of the vasculature in the retina. If these 
corrections were not performed, it would lead to disconnected vessel trees that are 
not representative of the true vascular network. The vessel segmentation is 
piecewise linear, whereby each segment of the skeleton is a straight line joined to 
another along the vessel path. This means that any small gaps between segments can 
be approximated by joining with a straight line. Corrections of type A were performed 
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by selecting the two edges that are to be joined and fitting a straight line. However, 
this was only performed when the distance between the two edges was small enough 
that a straight line represents the true path of the vessels. This means that larger 
gaps between segments that may have bends in the vessels were not corrected in 
this way because a straight line would not be representative of the vessel path. The 
judgement of performing such corrections (or not) was by a subjective decision made 
by me. Figure 5.5 (left) examples 4, 6 and 9 shows these corrections at various 
distances. In each of these cases, a straight line was deemed representative of the 
network and the manual correction results in a fully connected tree as shown in 
Figure 5.5 (right). 
Correction of type B were to ensure that when different vessels cross one another 
they are connected to the correct vessel tree. Figure 5.5 (left) examples 2, 5 and 9 
shows overlapping vessels that have been connected and then coloured according to 
the tree they belong to. This again was an important but time-consuming correction 
to make because if a branch from, for example, the pink tree at example 2 was 
connected to the blue tree, the vessel path would join at an invalid (i.e. anatomically 
incorrect) right angle and the path would incorrectly follow back on itself. Vessel 
width measurements made on an incorrect path such as this would result in an 
erroneous increase in vessel thickness and could be misinterpreted as vessels 
thickening when this was not the real case. 
Corrections of type C involved the removal of false positives that occurred as a result 
of artefacts being present in the image (Figure 5.5 (left) 1), or from retinopathy such 
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as drusen and exudates or from deep lying choroidal vessels (Figure 5.6). Corrections 
of type D were performed by removing vessels that were too short to obtain a width 
measurement from (Figure 5.5 (left) 10 and 8) or could not be correctly joined to a 
tree (Figure 5.5 (left) 3 and 7). This occurred in images with complex networks and 
the correction avoided any errors in the vessel tree. For example, Figure 5.5(left) 
example 7 was removed because this segment was a branch from the blue tree, but 
the segment end is from the main path of the pink tree. Such instances were deleted 







Figure 5.5 Overview of the manual corrections made in a portion of a segmented UWF image (left). The corrected network (right) where 
vessel trees are represented as different colours. We can see that by correcting the skeleton we have fluent trees extending from the 





Figure 5.6 Example of false positives (left arrows) due to peripheral drusen appearing near vessels, similar to drusen highlighted in the 
red box. Left shows the correction of type C that involves deletion of false positives.
150 
 
Following manual corrections, I labelled the vessel trees as arteriolar (A) or venular 
(V). AV labels were defined by visual inspection. Venules appear darker than arteries 
due to deoxygenated blood [192]. In addition, venular and arteriolar paths almost 
always cross one another (with arterioles on top) and not over themselves, and 
vessels usually alternate between venular and arteriolar paths around the OD. 
Following these rules, an accurate classification (previously reported to have an 
accuracy of 0.883 [192]) can be made in order to label each vessel tree as arteriolar 
or venular (Figure 5.7). 
 
Figure 5.7 A UWF image after complete manual correction process with all vessel 
trees separated and highlighted as A (red) or V (blue).  
5.2.3 Retinal vessel parameters 
 
Table 5.1 shows a summary description of the retinal vessel parameters that were 




An image is divided into the 4 quadrants (SN, IN, ST, IT) with the quadrants mirrored 
in the left and right eyes. Figure 5.8 (pink axes lines) illustrate the image quadrants 
which were centred and aligned according to the OD centre, the OD radius and the 
fovea centre (as observed by an axial tilt of the quadrants). The image is then divided 
into concentric zones - Zone A (0.5 to 1.0 OD diameters from the OD centre), Zone B 
(1.0 to 1.5 OD diameters from the OD centre), Zone C (1.0 and 2.5 OD diameters from 
the OD centre) and the periphery, which is any area outside of Zone C.  
 
Figure 5.8 The image zones. Peripheral zones are any area outside of Zone C. 
Within each quadrant, the longest arteriolar and venular path is selected to measure 
the WG (See Figure 5.9). The intuition behind this choice was to investigate the 
longest vessels that are carrying blood in and out of the retina in each quadrant. Once 
the arteriole and venule pairs are selected, the vessel widths are measured along 
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their paths where the WG is the gradient of the robust fit regression line that fits 
these data points [91]. WGa and WGv was calculated within each quadrant.  
 
Figure 5.9 Example of the longest arteriolar and venular vessel paths (green) in each 
quadrant (Q) from which the vessel width is then measured (in mm). The labels show 
SN (Q1), SN (Q4), IN (Q3) and IT (Q2) along with the computed width gradient. The 
raw segmentation of the vessels is overlaid in pink. 
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Tortuosity is a unitless measure [197] and describes how an object curves and twists. 
Curvature is estimated by measuring the ratio of the length of a curve between two 
points on the vessel path to the distance between the two points. A larger curvature 
would indicate that the vessel bends more within the two points. The global 
tortuosity values were then calculated using the sum of the squared curvatures 
divided by the length of the path.  Tortuosity was measured for arteriole and venule 
pairs for each vessel path using [196]. Fractal dimension (FD) is a unitless number 
used to quantify the complexity of a pattern and was first introduce in ophthalmology 
by Family et al [198]. FD is a method to measure an object that is made of repetitive 
patterns across different scales (i.e. self-similar). The retinal vasculature can be 
considered a self-similar pattern as it follows a tree structure where branches repeat 
and get smaller towards the periphery. FD is calculated by measuring the change in 
detail of the vessel tree (i.e. the white pixels) in the space it is contained (i.e. the black 
pixels) at different scales, which is achieved by overlaying boxes of decreasing size 
onto the vessel skeleton and counting the presence of white pixels [198].The FD was 
calculated for the arteriolar (FDa) and venular (FDv) binary maps using the methods 
from [194][195].  
As FD measures were calculated from the user-defined ROI, the total area covered 
by the ROI was also determined (in millimetres, Areamm2) for subsequent analysis. 
Figure 5.10 shows a visualisation of the complete set of ROI’s sampled for every 
image in the dataset. Overall, the FOV in a UWF image is larger than that of a fundus 
camera. The largest areas sampled were in the ST and IT zones. This is due to less 
155 
 
artefact from lashes and the device face plate being present in these regions 




Figure 5.10 Visualising all the ROI’s sampled over every image and in the whole 
dataset overlaid on a representative image. The whiter the area the more times this 
region was sampled. There is a skew to temporal quadrants as less artefact from 
eyelashes and eyelids was present in these regions.  
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5.2.4 Data cleaning and validation 
 
Prior to statistical modelling it was essential to identify any outliers in the measured 
parameters and assess whether they were valid or erroneous measurements. The 
intra-observer agreement was also considered in order to determine the 
repeatability of the vessel measurement process performed by myself (which 
contained points at which decisions are made about enacting manual corrections). 
WG parameters that could sometimes not be calculated due to obstruction of a 
vessel by an eyelash or eyelid. In the dataset, 58 CH, 26 MCI and 29 AD images had 
to be removed due to missing WG values. All vessel measures were assessed using 
boxplots to observe their distributions and identify potential outliers (see Figure 
5.11). Any measure that was beyond the 95% confidence interval of the set of 
measures was visually inspected by looking at the originating image and the 
corresponding vessel segmentation. The distribution of the TortA parameter is shown 
where it can be seen that the y-axis ranges by several orders of magnitude. TortA and 
TortV were log transformed to normalise the values (Figure 5.11B). Figure 5.11C 
shows an example of a TortA outlier from the AD group with the arteriolar paths 
overlaid onto the image. There were some extremely tortuous arteriolar vessel paths 
but there was also an erroneous segmentation (highlighted by the white arrow) that 
led to an invalid measurement. This data point was removed from subsequent 
analysis where all other outliers were visually inspected and deemed not to contain 




Figure 5.11. Example of a boxplots used to assess the data for outliers. A) A boxplot of the TortA vessel parameter. The y-axis is small 
and could be rescaled using a log transformation. B) Boxplot of the log transformed TortA. C) Example of a TortA outlier from the AD 
group with the arteriolar paths used to calculate TortA overlaid in white. This individual has extremely tortuous arteriolar paths giving a 





To investigate the repeatability of the vessel measures, 12 participants with left and 
right eye images (i.e. 22 UWF images) were randomly selected from the dataset (4 
CH, 4 MCI and 4 AD) for repeat ROI selection, manual correction and vessel 
measurements stages. Effect size (𝜉𝜉) was calculated using a heteroskedastic one-way 
ANOVA for trimmed means[199] . This was chosen because it is a robust method to 
explore data without making any assumptions for equal variance or normal 
distribution and removes any possible outliers introduced in repeats [200]. The 
analysis was conducted in R (version 3.4.4) using the R package ggstatsplot [201]. An 
effect size value was scored as small if 0.10< 𝜉𝜉 < 0.30, medium if 0.30 > 𝜉𝜉 < 0.50, and 
large if 𝜉𝜉 ≥ 0.50 [202]. Table 5.2 shows the results of comparing of the initial and 
repeated measure separated by left and right eye. It was observed that there was 
large effect size for area, FDa and FDv. In this thesis, a p-value is considered 
statistically significant if p<0.05 while small p-values are reported as ‘<0.0001’. There 
was a 40-70mm2 (6- 10% of the total area that can be captured in a UWF image) mean 
difference in area sampled, which was less in the initial analysis than the repeats and 
had a non-significant 𝜉𝜉 in the left eyes (p = 0.12) but a significant 𝜉𝜉 in left eye (p = 
0.01). This suggests that there was a significant variation in area as defined by me as 
the operator in left eyes. FDa was consistently larger in the left eyes of repeat 
measures than in the initial analysis and smaller in the right eyes of repeat measures, 
which was non-significant (p > 0.05). There was a mean difference of 0.20 in FDv of 
left and right eyes, which was significant (p < 0.001). This indicates that there was a 
significant increase in FDv in the repeat measures compared to the initial measures. 
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Given that significant large effect sizes were observed in both FDv and area measures 
of the ROI and the FD parameters are calculated from the entire ROI, two versions of 
the dataset will be analysed. The first is the initial data (referred to as the I-data) and 
a dataset with the original measures replaced with their repeats (referred to as the 
R-data). This was to investigate whether the differences between the initial and 




















5.2.5 Cleaned dataset 
 
Table 5.3 gives details of the participant demographics for the dataset following 
outlier removal. The final dataset contains 24 CH (41 eyes), 8 MCI (14 eyes) and 14 
AD (25 eyes) individuals. Comparison of the means was obtained using 1-way ANOVA 
(when normally distributed) and Kruskalwallis (when non-normally distributed). The 
MCI group contained more individuals with hypertension than CH and AD. Whether 
an individual involved in the study was taking antihypertensives was not known. 
There was a statistically significant difference in age (p= 0.01) and in MMSE score 
(p<0.05) between groups. Post hoc Tukey Kramer test (for ANOVA) and Dunn & Sidak 
(for Kruskalwallis) was used to identify where this difference lies. For age there was 
a significant difference between CH and AD (p<0.05) and not CH vs MCI or MCI vs AD. 












cleaned dataset the number of MCI participants was smaller than for the CH and AD 
groups and would not be enough to compare across 3 groups (i.e. using a test such 
as ANOVA) (see 5.2.5). For this reason, the analysis was conducted to investigate CH 
vs MCI and CH vs AD. 
The dataset consisted of repeated measures, where two eyes of an individual were 
included (as well as single eye images for some participants). Repeated measures 
tend to be correlated with one another, especially when measured over short time 
intervals. For example, if we are interested in how height and weight changes over a 
5-year period in 100 individuals, with measurements repeated twice a year, we know 
that there would be an underlying correlation between the repeated measures - i.e. 
two observations of an individual are more likely to be similar in value than two 
observations from two separate individuals. Similarly, we would not expect the two 
eyes in an individual to be independent as the underlying anatomy that connects the 
brain to the two eyes would be similar within an individual. For this reason, 
correlation between the measurements of two eyes of an individual should be 
considered during the analysis if possible. 
Standard statistical techniques such as Wilcoxon rank sum and logistic regression 
(considered in this chapter, as they do not assume a normal distribution) assume an 
independence between measures. Wilcoxon rank sum is a nonparametric analysis 
that does not require normal distribution. Logistic regression is a method to model 






(e.g. CRAE, CRVE) with use of multivariate analysis to control for potential 
confounders (e.g. age, ROI area). However, logistic regression does not permit a 
within-subject correlation structure. Table 5.4 summarises the models that were 








Generalised estimation equations (GEE) is a method by which repeated 
measurements (covariates such as, for example, CRAE) from a group of subjects (e.g. 
CH vs MCI) are used to model an expected response for an individual based on the 
covariate [206]. GEE is an extension of linear regression. In linear regression a line is 
fit by iteratively rotating a line through the data and measuring the squared distance 
(residual) of the data point to the fitted line and fitting the sum of the squared 
residuals (so called ordinary least squares [207]). The linear regression equation 𝑚𝑚 
for the jth vessel parameter in the ith individual is given by, 
𝑚𝑚𝑖𝑖𝑖𝑖 = 𝑎𝑎 + β𝑠𝑠𝑖𝑖𝑖𝑖 + 𝑒𝑒𝑖𝑖𝑖𝑖                               (5.1) 
OR 
𝐸𝐸�𝑚𝑚𝑖𝑖𝑖𝑖� = 𝑎𝑎 +  β𝑠𝑠𝑖𝑖𝑖𝑖; error = Normal.                    (5.2) 
Where 𝑎𝑎 is the intercept at 𝑠𝑠 in the independent variable (e.g. CRAE), β  is the 
gradient and 𝑒𝑒 the error term uncorrelated with 𝑠𝑠. The error term assumes a normal 
distribution and equal variance and is the standard error of the estimates. 𝐸𝐸�𝑚𝑚𝑖𝑖𝑖𝑖� 






link because it is a direct linear prediction of the dependent variable [206]. Figure 
5.13 shows what these parameters are in the model in a visual form. 
 
Figure 5.13 Illustrating the parameters in a linear regression equation. The 
hypothetical research question here is whether weight predicts the size. The 
equation for the regression coefficient (orange) is given by the intercept of the 
regression line 𝑎𝑎 (purple) at the independent variable weight (green; 𝑠𝑠) with a 
gradient (∇f) given by β (green). The error (𝑒𝑒) is the distance of the predicted value 
to the regression line. 
A GEE model extends the linear model in two ways. First, the correlation outcomes 
within an individual are taken into account in the regression formulae that generates 
the regression coefficients and their standard errors. Secondly, the GEE model does 






estimates for the standard errors and their coefficients [205]. GEEs thus provide a 
method by which standard errors and their coefficients give consistent inferences 
even if the strength of the correlation within observations of an individual varies 
[205]. A GEE model is given by Equation 5.4 and the within-subject correlation is 
modelled separately. GEE modelling can be thought of in five steps: 
1) Fit a standard regression model (Equation 5.1) where 𝑎𝑎 and β  are the 
regression coefficients.  
 
2) Take the residual of the jth observation in the ith individual in the regression 
model, which is given by, 
 
    𝑟𝑟𝑖𝑖𝑖𝑖 = 𝑚𝑚𝑖𝑖𝑖𝑖 (𝑎𝑎 + β𝑠𝑠𝑖𝑖𝑖𝑖)   .                        (5.3) 
 
3) Use the residual  𝑟𝑟 to form a matrix which is used to characterise the 
correlations between observations of an individual. This correlation structure 
is defined a priori. Equation 5.5 shows an exchangeable correlation structure 
and discussed more below). 
 
4) Refit the regression model as a weighted regression model by modifying the 








    𝑚𝑚𝑖𝑖𝑖𝑖 = 𝑎𝑎 + β𝑠𝑠𝑖𝑖𝑖𝑖 + 𝐶𝐶𝐶𝐶𝑟𝑟𝑟𝑟 + 𝑒𝑒𝑖𝑖𝑖𝑖     .                      (5.4) 
5) Generate new values for the regression coefficients (𝑎𝑎 and β)  and calculate 
new residuals (𝑟𝑟𝑖𝑖𝑖𝑖).  
 
6) Iterate through steps 2, 3, 4 and 5 until the estimates have stabilised and the 
model converges (i.e. the error is minimised between the residual and the 
regression line and the optimum model has been fitted). 
 
GEEs permit a within subject correlation structure to be defined a priori that makes 
some assumptions. Although multiple correlation structures exist such as 
independence (no correlation), autoregressive (within-subject correlation decreases) 
or unstructured (no specification), in this thesis an exchangeable correlation 
structure was chosen (Equation 5.5). Also known as, compound symmetry, an 






his or her two eyes. This is characterised by the intraclass correlation coefficient (ICC)  
[208], 
          (5.5) 
An exchangeable matrix was used to estimate the correlation parameter to quantify 
the within-subject correlation. In this matrix we have the residual (𝑟𝑟) for the ith 
individual in for both eyes (j, j+1). The correlation between repeated measures was 
calculated orthogonally using the ICC and is denoted as p and a dash (-) denotes which 
comparisons have not had applied – i.e. the p of the same eye of an individual. 
Comparison of the outputs informs me whether the significant p-value appearing to 
show evidence of a significant difference is an over estimation due to the fact that 
both the Wilcoxon rank sum test and ordinary least squares regression model ignore 
the inherent correlation between measurements - i.e. a Type I error (false negative) 
has occurred [209]. The use of a multivariate GEE model also permits the comparison 






cannot not be performed because the data in this study does not meet the model 
assumptions of normal distribution.  
It is against this backdrop that the group analysis was evaluated by comparing CH vs 
MCI, CH vs AD using Wilcoxon rank sum and univariate/multivariate GEE models to 
evaluate across all models how the signal from the p-value changed and evaluate 
possible Type I or Type II errors [210]. Table 5.5 in section 5.3.1 shows how the p-
value changed between each test. Given the variety of the outputs across models it 
appears that the correlation between eyes while controlling for other parameters 
would be the most reliable and robust result. For this reasoning, the multivariate GEE 
model is presented.  
Multivariate GEE analysis was performed whereby all independent variables were 
entered into the GEE formula and only included in the final multivariate model if 
statistically significant to the model. An independent variable is statistically 
significant if there is an association between the dependent variable and the 
independent variable of interest. If statistically significant, the variable is held 
constant so that the effects of the independent variable of interest to the dependent 
variable can be observed in the absence of this other association. Wilcoxon rank sum 








Each GEE model was implemented using the following code: 
geemodel = geeglm (Vessel parameter ~ Group, family = “gaussian”, 
corstr = “Exchangeable”) 
where the ‘corstr’ parameter is the assumed covariance matrix and the ‘family’ 
parameter assumes that the data follows Gaussian distributed (rather than a Poisson 
distribution which is typically applied in count data). The output of the model is the 
β-coefficient that is interpreted in a population averaged manner because it is 
calculated directly from the residuals after adjusting for all other covariates in a 
model. To illustrate, in this dataset I have calculated the regression coefficients from 
between the two eyes of an individual that can therefore be thought of as an 
‘average’ from that individual. When comparing between the groups, the 
comparison being made was essentially the comparison between the estimated 
average of all individuals. In this case, a positive or negative β-coefficient indicated 
the average increase or decrease of the population and the p-value and 95% 











5.3.1 Model comparison 
 
Table 5.5 summarises where significant differences were observed for the Wilcoxon 
rank sum (WRS), univariate GEE (UGEE) and multivariate GEE (MGEE) models when 
comparing CH with MCI and CH with AD (using the I-data). There was a significant 
difference in TortV (p = 0.01) when comparing CH and AD using WRS but this was 
non-significant in the UGEE and MGEE models (corrected for area and age). This 
suggested that there is a correlation of TortV measures between eyes that was 
accounted for in the GEE models and therefore was a false positive in the WRS model. 
There was no evidence of a significant difference in the WRS model for FDv but a 
significant difference was observed in the UGEE model (p = 0.01) and the MGEE 
model (p = 0.01) following correction for area. There was a significant difference of 
WGaST (p = 0.04), WGaIN (p = 0.02) and WGvIT (p=0.04) when comparing CH with AD 
using WRS.  Given that the signal for TortV, WGaST, WGaIN and WGvIT was not 
present when accounting for within subject variation, it suggested that the results 
would be more reliable when analysed using GEE’s. WGaIN and WGvIT signal was not 
present following correction for age which suggested that a multivariate GEE would 








The purpose of this analysis was to determine if accounting for within subject 
correlations was required to further analyse the data. If the signal did not change 
between models, it would suggest that within-subject variation is not essential for 
the analysis of the I-data and the R-data. The use of univariate and multivariate 
models indicated that correcting for age or area is required to give consistent results 
– as shown by the change in signal when comparing CH with MCI for the WGaIN and 
WGaIT following correction for age. 
5.3.2 Vessel width calibres 
 
Figure 5.14 shows boxplots of the CRAE and CRVE parameters measured for the three 
participant groups. Table 5.6 and Table 5.7 display the β-coefficients for the GEE 
univariate models with the I-data and R-data respectively. When comparing CH to 
MCI there was a decrease in CRAE and CRVE observed in the I-data and R-data but 
with no evidence of a statistically significant difference. When comparing CH to AD 
there was an increase in CRAE in the I-data and a decrease in CRAE in the R-data, but 
again no evidence of a significant difference. There was a decrease in CRVE in the I-
data and an increase in CRVE in the R-data that was non-significant. Outliers were 
observed in I-data and R-data for CRAE and CRVE and these were visually inspected 
to determine whether they might be invalid measurements. Figure 5.14 shows an 
example of this visual inspection in Zone B where the CRVE calibres are derived and 






CRVE (Figure 5.14B; 0.20mm2). In the outlier skeleton there is a smaller superonasal 







Figure 5.14 Boxplots of CRAE and CRVE measures in each group. A-B) boxplots of CRAE and CRVE measures from the I-data. C-D) boxplots 









WGaIN of the I-data and the R-data in boxplot form. Figure 5.16A shows an individual 
with AD and a mean WGaIN (-0.006) and an individual who is CH and who has a mean 
WGaIN (-0.005). From the boxplot it can be seen that the difference in WGaIN was 
from the CH group given by the larger mean WGaIN (-0.006) compared to the AD 
group (-0.005). The representative examples in Figure 5.16 show the vessel path from 
which the width gradient was calculated (cyan) displayed over the image and the 
widths measured along the vessel path. The AD individual appears to have a thinner 




















Figure 5.15 Boxplot of WGaIN for the I-data (A) and the R-data (B). The mean WGaIN for CH was the same in the I-data and R-data (-














Figure 5.16 A and B shows representative examples of an AD participant and CH participant, respectively. The main vessel arteriolar 
path from which the WGaIN is calculated is overlaid in cyan on to the image. The individual widths measured along the path are displayed 
underneath where a straight line is fitted to the data points.  The AD individual appears to have thinner widths measured along the path 






5.3.4 Vessel tortuosity and fractal dimensions 
 
Table 5.10 and Table 5.11 display the GEE analysis with the I-data and R-data, 
respectively. When comparing CH with MCI there appeared to be a decrease in TortA 
and TortV in the univariate GEE models using both the I-data and the R-data, though 
there was no evidence of a significant difference. Figure 5.16 shows the FDa and FDv 
distribution derived from the I-data and the FDa and FDv from the R-data. 
Comparison of CH with MCI showed an increase in FDa but no evidence of this being 
a significant difference (following correction for area). Comparing CH with AD showed 
an increase in FDa (p = 0.20) in the I-data, following and prior to, correcting for area 
and age where there was no evidence of a significant difference.  In the R-data when 
comparing CH to AD showed an increase in FDa where a significant difference prior 
to and following correction for area was observed (p = 0.01). Comparing CH with MCI 
there was a significant increase in FDv (p = 0.01) prior to and following a correction 
for area in the I-data and an increase in FDv in the R-data, though not with a level 
considered significant (p = 0.71). In the R-data, comparing CH with AD seemed to 
indicate a decrease in FDv, but this was without achieving a level of significance. From 





















Multivariate GEE modelling was concluded to be a reliable and consistent method for 
analysing datasets that contain within subject correlations. This was shown by the 
variation in signal when comparing to other non-parametric modelling techniques, 
which suggested that these methods may be prone to Type I errors when analysing 
retinal datasets. In [210], the authors showed that ignoring the correlation between 
eyes of an individual can lead to an inflated p-value when using paired tests. This was 
observed in this Chapter and showed that the result for my venular tortuosity 
parameter (TortV) was a false positive when using Wilcoxon rank sum and univariate 
logistic regression to compare between groups. Changes in tortuosity have previously 
been reported in the literature when analysing fundus images of individuals with AD, 
though results have been inconsistent. In [48], the authors reported an increase in 
arteriolar and venular tortuosity and used multivariate logistic regression in their 
dataset that contained both eyes of an individual. In [112], the authors reported a 
significant decrease in venular tortuosity but no change in arteriolar tortuosity and 
used a χ2 test to compare a dataset containing both eyes of individuals with AD and 
healthy controls. In [213], authors used logistic regression to analyse fundus images 
of CH and AD individuals using right eyes only. The authors reported a significant 






confounders (e.g. age, hypertension). Although the authors used only the right eyes 
it would be interesting to see whether this significance persists in the left eyes. If the 
significance did not persist when analysing eyes separately it would suggest that 
there is variation between eyes that needs to be included in the model to give a more 
accurate representation of the data and to determine any differences between AD 
and CH groups. Given the inconsistencies in the literature, more data is needed to 
understand the role of tortuosity as a potential biomarker for pathological cognitive 
decline but statistical techniques such as multivariate GEE would allow for a reliable 
and consistent analysis. 
In my dataset, there was a significant increase in the complexity of the arteriolar 
network (FDa) observed when comparing CH with AD in the repeat data, but this was 
not recurrent in the initial data. Similarly, a significant increase in the complexity of 
the venular network (FDv) was observed when comparing CH with MCI in the initial 
data, but the finding was not observed in the repeat data. The likely source of this 
disparity is from the variation in the area which FD was calculated, which has three 
possible effects on the measure. In general, more area was included in the repeat 
data than the initial data (see section 5.3.4). An increase in area increases the amount 
of the vasculature that is used for the fractal dimension calculation and could result 
in a larger value. Figure 5.18 shows an example of a CH individual who showed an 
increase in FDa on repeat analysis. The initial ROI (white) and the repeat ROI (green) 






venular paths are shown in red and blue, respectively. The extension of this 
segmentation in the repeat analysis is also displayed with arteriolar and venular paths 
are shown in cyan and magenta respectively. Either the additional paths can occur 
from the ROI positioning capturing more of the vasculature or from differences when 
performing the manual correction of stages (e.g. a path was removed in the initial 
analysis but not in the repeat). In this example, the ROI area has increased from 
396mm2 to 643mm2, which has led to an increase in FDa from 1.38 to 1.46 and an 















Figure 5.18 Image illustrating the increase in FDa and FDv that can occur due to a 
larger ROI in the repeat analysis (green circle) compared to the initial ROI (white 
circle). The initial arteriolar and venular paths are shown in red and blue respectively. 
The extension of the arteriolar and venular paths in the repeat analysis are shown in 
cyan and magenta, respectively.  
It is also possible for an increase in ROI area to lead to a decreased fractal dimension. 
This is because the fractal dimension calculation takes into account the empty black 
space (i.e. non-vessel pixels) as well as the object (i.e. vessel pixels) to quantify the 
complexity of the structure (i.e. the vessel pattern). In individuals with a sparser 






5.19 shows an example of an individual who had a low FDa and FDv measures in both 
the repeat and the initial analysis. The initial ROI (white) and the repeat ROI (green) 
has increased by 68.2mm2, leading to a decrease in FDa and FDv by 0.12 even though 
the arteriolar and venular paths are the same in both analysis.  
 
 
Figure 5.19 Image illustrating how an individual with a sparse vasculature network 
can show a decrease in FDv and FDa due to more empty space being introduced by a 
larger ROI in the repeat (green circle) compared to the initial ROI (white circle) even 
though the segmentation remained the same. Arteriolar network is labelled red and 







A different segmentation on the repeat analysis can lead to a different FDa or FDv 
value despite the size of the ROI. Figure 5.20 shows a CH individual with the initially 
segmented vasculature and the initial ROI (white) and the repeat ROI (green) overlaid 
onto the image. In this individual, the original ROI is 60mm2 larger than the repeat 
ROI. The arteriolar (red) and venular (blue) trees from the initial segmentation are 
overlaid with the extension of this segmentation in the repeat (arteriolar – cyan; 
venular - magenta) analysis is also shown. In this individual, the repeat segmentation 
was different due to variation in manual correction stage and a smaller ROI than the 
initial ROI capturing less empty space. This resulted in an increase FDa from 1.47 to 









Figure 5.20 An image of an individual that showed an increase in FDa and FDv in the 
repeat analysis despite the larger ROI in the initial analysis (white circle) compared to 
the repeat analysis (green). The initial arteriolar (red) and venular (blue) 
segmentation original is overlaid with the extra (cyan) and venular (magenta) paths 
found in the repeat. The segmentation in the repeat analysis included more smaller 
branching vessels contributing to the increase in FDa and FDv values. 
It can be concluded that in the repeat data more of the UWF image was sampled and 
this led to variations in the fractal dimension results. In previous work, a significant 
decrease in FDa was observed in AD individuals compared to controls, i.e. sparser 
arteriolar vascular network [91]. The sampling area affected the FD value even 






measure has previously been shown to be influenced by ROI placement [214]. The 
effects of the ROI placement on FD values could be overcome in future analysis by 
defining a consistent zone for extracting the FD measure throughout the dataset or 
to develop a new metric of branching complexity of the retinal vasculature in UWF 
images (i.e. standardisation of FD calculations) (see Chapter 7). My results show that 
researchers working in this field should take great care when interpreting FD 
measures and that reporting a repeat analysis would be important to demonstrate 
that the analysis is consistent and the results are reliable. 
There was a consistent significant difference in WGaIN when comparing CH with AD 
that was present in the both the initial and repeat data. Previously, an increase in 
WGvSN was observed in UWF images of individuals with AD [91] but this was not 
observed in this dataset.  In their study, the authors also described an increase in 
peripheral drusen that was located in the superonasal quadrant. They hypothesised 
that the increased WGvSN in AD resulted in venular thinning and suboptimal 
clearance of the peripheral retina leading to drusen deposition. This study involved 
59 AD (mean age 79 years, SD 8.4 years) and 48 healthy controls (mean age 71 years, 
SD 10.4 years) and therefore had more AD participants than in my study while all 
their participants were older and better age-matched than the participants in the 
dataset analysed in this chapter. These factors could explain why I was not able to 






WGaIN increase, observed in this dataset, has a correlation to drusen deposition (see 
Chapter 6).  
All participants in this study were over the age of 50 and changes to the retinal 
structure and function that occur in natural ageing of the eye would likely be present. 
Hence, subtle biomarkers specific to diseases such as AD might be difficult to discern 
from natural ageing.  
5.5 Conclusions 
 
GEE’s are a consistent and robust method to provide valid inference of retinal 
datasets that contain both eyes of an individual.  Given the inconsistent results of 
fractals that were observed, it is difficult to conclude whether fractal dimension 
might associate with AD. This chapter has highlighted the need for the 
standardisation of extracting fractal dimension measures, particularly when 
performed on a UWF image that has a larger FOV than a traditional fundus camera. 
The retinal vascular data presented here suggests that there may be subtle changes 
occurring in the retina in pathological cognitive decline pertaining to AD. It is believed 
that changes occurring in the brain connected to AD occur much earlier than the 
outward presentation of symptoms of significant cognitive decline. Thus, retinal 
vascular changed mirror brain vascular changed could also occur much earlier in life. 








 It is believed that changes occurring in the brain connected to AD occur much earlier 
than the presentation of significant cognitive decline. Thus, retinal vascular changes 
that mirror brain vascular changes could also occur much earlier in life. Longitudinal 






















This chapter outlines the exploratory analysis of the dataset presented in Chapter 5 
using the automatic system described in Chapter 4. Quantitative measures 
performed on UWF images could be used to study cross-sectional differences 
between patients or longitudinal changes in individuals to facilitate investigations 
into drusen formation and progression as a biomarker of neurodegeneration. 
However, because the detector had a low sensitivity we should bear in mind that 
there will be a large proportion of drusen that are not detected giving an under 
estimation of the true amount present in an image. In this chapter I investigate 
differences between individuals deemed cognitively healthy and those with MCI and 
AD.   
6.2 Materials and methods 
 
93 CH, 41 MCI and 50 AD images were analysed for drusen. This dataset comprised 
images prior to data cleaning (Section 5.2.4) of invalid measurements of vessel 
parameters. One image from a CH individual was excluded due to the presence of 
artefact (see Figure 6.2). Drusen were detected using the automatic system described 






cell is classified as either positive for drusen or negative for drusen. Counts of grid 
cells deemed positive were obtained for each of the zones previously described in 
Section 4.3.4 as well as an overall total drusen load for every image. In Section 4.3.2 
the ROC curve showed the performance of the classifier at various thresholds. At a 
threshold of 0.5 the curve was closest to the top left corner of the ROC plot and 
represents the optimum threshold whereby the true positive rate is maximised and 
false positives are minimised. A cell was considered positive if the output probability 
value was more than 0.5.  
Figure 6.1 shows the distribution of the total counts per image visualised as a dot 
plot. Given the low sensitivity of the drusen detector the images with high counts 
were visually inspected to assess whether these featured cells that were false 








Figure 6.1 Dot plot of the total count of Manchester grid cells classified as positive for 
drusen. There were many images with high counts of cells detected as positive for 
drusen in the AD and CH group.  
Figure 6.2A shows the output of the drusen detector visualised as a heatmap in an 
individual who had a high drusen count. Closer inspection of the image in Figure 6.2B 
shows that there were large amounts of bright material that is most likely vitreous 
material, which confounds the automatic system. As this image contained an 
extremely large number of false positives, the image was excluded from further 
analysis. This individual’s fellow eye was visually inspected to assess whether the 






were visually inspected (see Figure 6.2D) and found to contain clusters of hard and 
soft drusen rather than the previously observed bright vitreous material, and so the 












Figure 6.2 A CH individual with large amounts of vitreous material in their right eye 
but not the left. A) The output from the system was a high probability that these 
regions contained drusen (white). B) On closer inspection vitreous material was 
observed in the inferior region of the image and this has a similar appearance to 
drusen is present in the inferior region of the image. C) For the image of the fellow 
eye the output of the drusen detection was inspected for artefact (yellow boxes). D) 
The regions of high probability were visually assessed and deemed to contain clusters 







On visual inspection of 16 images suspected of containing large numbers of false 
positives, they were actually from individuals who had large amounts of drusen. 
Figure 6.3 shows an example of this along with the image obtained from the fellow 
eye for comparison. There was a region of high probability near to the OD. Given that 
this was a source of false positives (see Section 4.3.2) the area was visually inspected 
and deemed to contain drusen (white arrows) but also false negatives (purple arrow). 
All 16 images appeared to contain low numbers of false positives and were all 
















Figure 6.3 A) the right eye of the individual where a region near the OD was assessed 
by the automatic system to contain a high probability for drusen. (B) This region was 
visually inspected and shows true positives near the OD (white arrows) and false 
negatives (purple arrow). (C) This individual has a high abundance of drusen in the 
fellow eye.  
 Table 6.1 shows the participant demographics following removal of the one outlier 
(shown in Figure 6.2. There was no evidence of a significant difference between ages 
for the 3 groups but there was a significant difference in Mini Mental State Exam 









for GEE analysis because some images could have no drusen detected in any one of 
the zones. This would result in many 0 values which can be avoided, wherever 
possible, by using the total count detected in the image.  
6.3 Results 
 
6.3.1 Drusen detection 
 
Figure 6.4 shows as a percentage the total number of cells detected as positive for 
drusen per zone and split by group. There were a total of 635, 112 and 384 cells 
detected as drusen in the CH, MCI and AD groups, respectively. MCI had a higher 
number of cells detected as positive for drusen in the central zone (35 cells, 31%) 
than CH (19 cells, 3%) and AD (82 cells, 21%). CH had a higher number of drusen 
positive cells in the perimacular zone (289 cells, 46%) than MCI (35 cells, 31%) and 
AD (82 cells, 21%). AD had a higher number of cells detected as positive for drusen in 








Figure 6.4 shows as a percentage the total number of cells detected as positive for 
drusen per zone and split by group.  
6.3.2 Drusen and age 
 
Figure 6.5 explores the relationship between age and the total number drusen 
positive cells in the whole dataset. I observed a statistically significant (weak) positive 
correlation (R = 0.30, p < 0.01). By group, there was a statistically significant 
(moderate) positive correlation between drusen count and age in CH (R = 0.40, p < 






in MCI (R = 0.30, p = 0.06) and in AD (R = 0.30, p = 0.06). The drusen detector and our 
dataset replicated the previously reported association of increasing drusen 
abundance with age, even though the network sensitivity was low and the counts 
were most likely under estimated. 
 
Figure 6.5 A plot of age against total drusen count for each individual, which shows a 
linear relationship. The purple line indicates the correlation of the two parameters 
and the 95% confidence intervals. There was a weak positive correlation between age 
and drusen counts (R = 0.30, p < 0.01). It can be seen that individuals with higher 








show this for the CH group where it can be seen that there was a large proportion of 
high probability in the inferior nasal region of the perimacular and peripheral zone. 
Figure 6.5 C (left eye) and D (right eye) show the average probability in the MCI group 
where there were smaller regions of high probability cells than observed in the CH 
group. These look to be distributed around the perimacular and peripheral zones. 
Figure 6.5 E (left eye) and F (right eye) show the average probability for the AD group 
where there was a large high probability region in the inferonasal region (peripheral 
zone) of the left and right eyes that is similar in pattern to the CH group. This analysis 
suggests that there were less drusen in the perimacular and peripheral zones in MCI 












Figure 6.5 Visualising the drusen cell probabilities, where higher average probabilities 
correspond to a whiter colour on the colour scale and lower probabilities correspond 
to the darker end. (A) and (B) correspond to the CH group, (C) and (D) to the MCI 
group, (E) and (F) to the AD group. It can be seen that there are different patterns in 
drusen distribution. The CH and AD groups both contained large regions of high 
drusen probability in the inferornasal regions whereas drusen probabilities look more 
dispersed in MCI eyes. The green marker indicates the OD. The blue lines delineate 
the zones as defined in Chapter 4. 
6.4 Discussion  
 
The aim of this chapter was to use the automatic drusen detection system to 
investigate associations between drusen deposition and neurodegeneration in the 
context of AD. Drusen deposition was associated with age in my dataset (R = 0.40, p 
< 0.05), which agrees with previous reports [215][216][217]. Though it should be 
remembered that my system has low sensitivity and so there could have been false 
negatives that would give an underestimation of the true drusen load in an image. It 
would be interesting to observe the heatmaps in longitudinal images to monitor 
drusen progression in people split by zones to see whether this differs between the 
groups. However, improvements to the system such as more training data would be 






improvements, the analysis in this chapter could be conducted to highlight whether 
the trends observed in this thesis persists. 
There was a higher abundance of drusen positive cells in the inferonasal region of the 
peripheral retina in CH (51%) and AD (58%) individuals and less was observed in MCI 
(38%). Csincsik et al [91] proposed that the thinning of the vasculature towards the 
periphery would decrease blood flow and could lead to decreased oxygenation, 
nutrient availability and suboptimal clearing of the peripheral retina. Previous studies 
demonstrating retinal changes in MCI and AD have shown that blood flow 
abnormalities precede neurodegeneration [218]. In Chapter 5 when comparing CH 
with AD there was significant difference between the inferonasal arteriolar width 
gradient. This could suggest that the high abundance of drusen detected in this region 
may be related to a thinner inferonasal arterioles leading to suboptimal clearance 
and drusen deposition.  
In Chapter 5, there was no evidence of a significant difference between CH and MCI 
inferonasal arteriolar width gradient, but 60% of MCI individuals were hypertensive 
(Section 5.3.4). MCI had significantly different drusen counts when comparing to CH 
(p = 0.02) and AD (p = 0.003). It could be that drusen were not observed in this region 
for MCI because individuals were taking antihypertensives that may have improved 
blood flow and thus minimised drusen deposition. The data on hypertensive 
medication was not available for this thesis but would be important for future studies 






There was a statistically significant difference between the number of drusen positive 
cells when comparing CH with AD (p = 0.02) and CH with MCI (p = 0.003). High 
probabilities were located in the perimacular and peripheral zones. A metanalysis of 
RNFL thickness measured using OCT in AD and MCI compared to healthy controls 
found that there was an association between RNFL thinning of the superior and 
inferior quadrants [219]. Additionally, there is a higher concentration of ganglion cells 
in the nasal quadrant than the temporal quadrant of the perimacular zone [75]. RGC 
degeneration has been associated with AD [101][220] as well as amyloid deposition 
in the retina [52][93]. This could explain the higher rates of drusen detection in this 
region as a higher concentration of degenerating cells may lead to increased drusen 
accumulation. More data and improvements to the drusen detector (as outlined 
above) would be required to determine whether this pattern persists. 
Csincsik et al [91] found that there was a higher abundance of peripheral hard drusen 
in AD. This raises the question as to whether drusen type helps to distinguish 
accumulation associated with age or with ganglion cell degeneration and amyloid 
deposition that may precede cognitive decline. Post mortem histology analysis of 
drusen deposits composition may shed light onto the differences between age-
related drusen and drusen associated with cognitive decline. It would be interesting 
to curate datasets featuring UWF images and corresponding post mortem histology 






molecular composition. This may aide in the identification of imaging characteristics 
that define drusen containing amyloid and further identify AD retinal biomarkers.  
6.5 Conclusions 
 
This chapter explored drusen load in CH, MCI and AD individuals using an automatic 
deep learning-based system. Although the sensitivity of the system was low and the 
drusen counts were most likely underestimated, the output of the system was able 
to replicate a previously reported association of drusen and age.  There was 
significantly less drusen detected in MCI compared to AD and CH. AD had a higher 
proportion of drusen counts in the periphery compared to MCI and CH that replicates 
previous work using manual annotations of drusen in UWF images. Improvements to 
the system, such as more training data, would be required to assess whether these 















Inspired by previous work in fundus photography, a novel computerised technique to 
automatically detect drusen in UWF images was developed in this thesis. Retinal 
vascular measurements and drusen counts were obtained and assessed in a patient 
cohort that featured AD and MCI as well as CH individuals - to identify potential 
biomarkers and retinal manifestations of disease. 
The following were the major aims and advancements achieved by this thesis: 
1) Aim 1 was to investigate methods for automatically detecting and analysing 
drusen in UWF images. This was achieved by investigating previous work in 
detecting drusen in fundus camera images (primarily in the field of AMD). This 
highlighted the direction of research moving towards deep learning and 
transfer learning, which subsequently inspired my development of drusen 
detection for UWF images 
2) Aim 2 was to cultivate an automatic drusen detection algorithm. This was 
achieved through development of a supervised deep convolutional neural 
network to classify patches within a UWF image as positive or negative for 






the central, perimacular and peripheral regions of the retina, respectively. 
This provided a novel method to identify regions that had a high probability 
of containing drusen. This has utility for quantifying drusen (by counting the 
number of positive patches) and for monitoring drusen progression 
(visualising the output via a heatmap). The system had a low sensitivity (17.7-
21.8%) which means there would be a high number of false negatives, 
therefore utilising the system for quantifying drusen in a new dataset would 
result in an underestimation of the true amount of drusen present in the 
images. The nature of many of these false negatives were instances of small 
discrete drusen that might only be 1 pixel in size or dust artefact on the mirror 
of the SLO. In both cases, a human grader might have more success where the 
system failed. However, there was only a moderate agreement between two 
observers grading images (κ = 0.53, DSC = 0.38), which highlights the difficult 
nature of manually annotating drusen in UWF images. This also created a 
challenge to validating the system in the presence of observer disagreement.  
These limitations could be overcome by training the system on more data and 
additional observers to create a more consistent reference standard. 
3) Aim 3 was to measure and analyse the retinal vasculature in AD to investigate 
retinal manifestations and discover potential biomarkers. Multivariate GEE 
analysis was used to compare between groups of CH, MCI (considered in this 






eyes. I found a significant difference between arteriolar inferonasal width 
gradients of CH and AD. There were inconstancies between fractal dimension 
measurements in the repeat analysis, where this thesis identified limitations 
in marking non-standardised ROI in the UWF image set. My work did highlight 
a robust statistical analysis method for UWF retinal vasculature 
measurements as well as issues to overcome in future studies. 
4) Aim 4 was to apply the drusen detector to the dataset consisting of CH, MCI 
and AD in order to quantify drusen in these images and identify differences 
between the groups. This was conducted as an exploratory analysis due to the 
limitations of the proposed system, i.e. low sensitivity. The exploratory 
analysis produced promising results as the output of the system was 
successful in replicating a known association between drusen and age as well 
as uncovering novel differences between groups. Using GEE, there was a 
significant difference in drusen count when comparing MCI to CH (p = 0.02) 
and MCI to AD (p = 0.03), but no evidence of a significant difference when 
comparing AD to CH (p = 0.30). Visual inspection of the output of the 
automatic system via a heatmap showed that there were higher probabilities 
of drusen in the inferonasal region of CH and AD, which corresponded with 







7.2 Future work 
 
The human observers used a Manchester grid to grade cells for drusen, and the 
proposed system was validated in a way to correspond to this grading protocol. This 
limited the FOV due to the curvature of the grid towards the periphery that could not 
be resized for input into the neural network, and subsequently led to grid cells which 
could not be classified for drusen. Additionally, drusen grading is highly subjective as 
there was not a clear enough protocol for the human observers to follow, particularly 
when encountering a Manchester grid cell with drusen at the edge of the cell 
boundary. One observer may grade for drusen and the other may not. This created a 
level of disagreement between the observers and led to challenges when validating 
the neural networks performance. Future reference standards should therefore 
include a grid that extends to the periphery perhaps by using a system that does not 
account for the retinal curvature in this region (i.e. a square cell) and precise grading 
protocols as to how to grade drusen at the edge of a cell. This would improve the 
quality of the ground truth which is necessary for both training and validating an 
automatic system. 
Neural network performance could be improved with more training data. This data 
could consist of patches graded for different subtypes of drusen and dust (to train 
the network to identify false positives). As drusen size is used in many AMD studies 






in the UWF image. Semantic segmentation, whereby each pixel is given a class, could 
be used provided that the training data contains large amounts of hand drawn 
segmentations by multiple observers. Individual hand drawn boundaries of drusen 
would be challenging in UWF images because of the resolution of the imaging 
technique as drusen might be only a few pixels in size. Obtaining large amounts of 
pixel level annotations would be challenging, expensive and time consuming where 
multiple observers would be needed to obtain a reliable reference standard. 
Subsequently, ensembles of neural networks, whereby stacks of networks that 
perform different tasks in order to create a combined output, could be developed. 
For example, one network could classify the image as containing drusen or not, where 
images high risk for drusen are passed to a second network. The second network 
could classify patches for drusen where patches with a high probability for drusen are 
passed to a third network. The third network could perform semantic segmentation 
to delineate drusen boundaries for drusen quantification.  This coupled with OCT 
images that could be used to segment drusen volumes, may provide further insight 
into the type of drusen present. Such multimodal imaging ensemble learning 
methods would require large amounts of data, meticulous hand drawn 








There was inconsistency between repeat measures of fractal dimensions that 
resulted from the varying nature of the ROI used in performing the calculation. To 
overcome this, a predefined ROI could be used on each image, for example a ‘Zone 
D’ that is an annulus that extends further from Zone C. However, in a UWF image 
obtaining a circular area is challenging because of the eyelashes and eyelids that 
sometimes feature in the image. An ellipse shape is often more appropriate. This 
ellipse could be obtained by taking the average manually drawn ROI over the whole 
dataset (that is positioned according to the OD and fovea) so that the fractal 
dimension is calculated from the same region in each image. The challenge with such 
an approach is that not all of the vasculature might be measured in some images. 
Another way to address the challenge might be to develop a new metric of branching 
complexity. The data structure of the vascular segmentation is a graph, whereby the 
nodes are the branching points, the edges are the vessels to the node and there are 
multiple vessel graphs in one image that corresponds to the arteriolar or venular 
components. This data structure is synonymous to a computer program where the 
nodes can be a conditional statement, the edges are the routes from the statement 
and there can be a number of graphs that corresponds to the number of subroutines 
or classes. Software developers use this to measure the complexity of the graph (i.e. 
the complexity of the software), called cyclometric complexity [221]. This returns a 
value between 1 and 10, where 10 is most complex. Potentially the cyclometric 






vasculature. The challenge here is that the performance of the segmentation would 
have an influence on the number of edges and nodes and therefore impact the value 
of the complexity – i.e. a low cyclometric complexity could be returned because not 
all of the vasculature could be segmented in a poor quality of the image. However, 
the question would be whether this method is more repeatable than a fractal 
dimension. Comparisons of fractal dimension and cyclometric complexity measures 
would be required to validate a new metric of vascular branching complexity.  
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